Processing 00000000.tx.1: Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90 David Fulton,1 M. 

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "diminish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "eNOS expression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "binding to HSP-90 David Fulton,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   822   C1523546:heat shock protein binding [Molecular Function]
   767   C0033618:Protein Binding [Molecular Function]
   767   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "1 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Brennan Harris,1 Bruce E. 

Phrase: "Brennan Harris,"

Phrase: "1 Bruce E."
Processing 00000000.tx.3: Kemp,2 Richard C. 

Phrase: "Kemp,"

Phrase: "2 Richard C."
Processing 00000000.tx.4: Venema,1 Mario B. 

Phrase: "Venema,"

Phrase: "1 Mario B."
Processing 00000000.tx.5: Marrero,1 and David W. 

Phrase: "Marrero,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "David W."
Processing 00000000.tx.6: Stepp1 1Vascular Biology Center and Departments of Physiology and Pharmacology, Medical College of Georgia, Augusta, Georgia 30912; 

Phrase: "Stepp1 1Vascular Biology Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Departments of Physiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "Medical College of Georgia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "Augusta,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1189407:Augusta [Plant]

Phrase: "Georgia 30912"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0017452:Georgia [Geographic Area]
   861   C0017454:Georgia [Geographic Area]
   789 E C0337804:georgian [Population Group]

Phrase: ";"
Processing 00000000.tx.7: and 2St. 

Phrase: "and"

Phrase: "2St."
Processing 00000000.tx.8: Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia Submitted 22 March 2004 ; accepted in final form 15 July 2004  ABSTRACT TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Previously, using an animal model of syndrome X, the obese Zucker rat (OZR), we documented impaired endothelium-dependent vasodilation. 

Phrase: "Vincent's Institute of Medical Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Fitzroy,"

Phrase: "Victoria 3065,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042645:Victoria [Geographic Area]
   861   C0997115:Victoria [Plant]

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "22 March 2004"

Phrase: ";"

Phrase: "accepted in final form 15 July 2004  ABSTRACT TOP ABSTRACT MATERIALS"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   738   C0000857:Abstract [Occupational Activity]
   738   C0205088:Final [Temporal Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C0520510:Materials [Substance]
   738   C0600678:Abstract [Intellectual Product]
   738   C1272684:Accepted [Qualitative Concept]
   738   C1522492:Form [Functional Concept]
   738   C1546485:Final [Idea or Concept]
   738   C1548435:Accepted [Idea or Concept]
   738   C1552863:Abstract [Idea or Concept]
   738   C1704458:Top [Spatial Concept]
   704 E C1548601:Accept [Idea or Concept]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Previously,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an animal model of syndrome X,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599779:Animal Model [Animal]
   753   C0003062:Animal [Animal]
   753   C3161035:Model [Intellectual Product]

Phrase: "the obese Zucker rat (OZR),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "we"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "impaired endothelium-dependent vasodilation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0042401:Vasodilation [Physiologic Function]
   812   C0595862:VASODILATION [Pathologic Function]
   812   C3537065:Vasodilation [Physiologic Function]
Processing 00000000.tx.9: The aim of this study was to determine whether reduced expression or altered posttranslational regulation of endothelial nitric oxide synthase (eNOS) underlies the vascular dysfunction in OZR rats. 

Phrase: "The aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "reduced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "altered posttranslational regulation of endothelial nitric oxide synthase (eNOS)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514251:Post-Translational Regulation [Molecular Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "underlies"

Phrase: "the vascular dysfunction in OZR rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031847:dysfunction [Functional Concept]
   744   C0277785:Dysfunction, NOS [Qualitative Concept]
Processing 00000000.tx.10: There was no significant difference in the relative abundance of eNOS in hearts, aortas, or skeletal muscle between lean Zucker rats (LZR) and OZR regardless of age. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in the relative abundance of eNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]

Phrase: "in hearts,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018787:Hearts [Body Part, Organ, or Organ Component]
   966 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "aortas,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003483:Aortas [Body Part, Organ, or Organ Component]
   966 E C1278934:Aorta [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "skeletal muscle between lean Zucker rats (LZR)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   790   C0242692:Muscle, Skeletal [Tissue]
   790   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   753   C0026845:Muscle [Tissue]
   753   C0037253:skeletal [Body System]
   753   C0521324:Skeletal [Spatial Concept]

Phrase: "and"

Phrase: "OZR regardless of age."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0034719:Zucker rat [Mammal]
   753   C0028754:Obese [Disease or Syndrome]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C2700303:Zucker [Mammal]
Processing 00000000.tx.11: There was no difference in eNOS mRNA levels, as determined by real-time PCR, between LZR and OZR. 

Phrase: "There"

Phrase: "was"

Phrase: "no difference in eNOS mRNA levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "as"

Phrase: "determined by real-time PCR,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   862   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   806   C1550177:Real Time [Idea or Concept]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040223:Time [Temporal Concept]
   760   C0237400:Real [Qualitative Concept]
   760   C0677874:pCR [Finding]
   760   C3272377:REAL [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "between LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "OZR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.12: The inability of insulin resistance to modulate eNOS expression was also documented in two additional in vivo models, the ob/ob mouse and the fructose-fed rat, and in vitro via adenoviral expression of protein tyrosine phosphatase 1B in endothelial cells. 

Phrase: "The inability of insulin resistance to"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "eNOS expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "also"

Phrase: "documented in two additional in vivo models,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   793   C1515657:In Vivo Model [Research Activity]
   774   C1515655:In Vivo [Spatial Concept]
           vivo
   748   C0205448:Two [Quantitative Concept]
   748   C1301725:Documented [Health Care Activity]
   748   C1524062:Additional [Functional Concept]
   748   C1609436:documented [Idea or Concept]
   748   C3161035:Models [Intellectual Product]
   714 E C1301746:document [Intellectual Product]
   714 E C1547673:Document [Intellectual Product]

Phrase: "the ob/ob mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "the fructose-fed rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "in vitro via adenoviral expression of protein tyrosine phosphatase 1B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021135:In Vitro [Intellectual Product]
   760   C1533691:in vitro [Qualitative Concept]
           vitro
   760   C2827718:In Vitro [Functional Concept]

Phrase: "in endothelial cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.13: We next investigated whether changes in the acute posttranslational regulation of eNOS occurs with insulin resistance. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "changes in the acute posttranslational regulation of eNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   704 E C1705241:Change [Quantitative Concept]

Phrase: "occurs with insulin resistance."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.14: Phosphorylation of eNOS at S632 (human S633) and T494 was not different between LZR and OZR; 

Phrase: "Phosphorylation of eNOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "at S632"

Phrase: "(human S633"

Phrase: ")"

Phrase: "and"

Phrase: "T494"

Phrase: "was"

Phrase: "not different between LZR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: ";"
Processing 00000000.tx.15: however, phosphorylation of S1176 was significantly enhanced in OZR. 

Phrase: "however,"

Phrase: "phosphorylation of S1176"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "enhanced in OZR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034719:Zucker rat [Mammal]
   760   C0028754:Obese [Disease or Syndrome]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C2349975:Enhanced [Activity]
   760   C2700303:Zucker [Mammal]
Processing 00000000.tx.16: Phosphorylation of S1176 was not different in the ob/ob mouse or in fructose-fed rats. 

Phrase: "Phosphorylation of S1176"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "not different in the ob/ob mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "or in fructose-fed rats."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0016745:Fructose [Carbohydrate,Pharmacologic Substance]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0342895:FED [Disease or Syndrome]
   726 E C0204695:Feed [Health Care Activity]
   726 E C2987508:Feed [Activity]
Processing 00000000.tx.17: The association of heat shock protein 90 with eNOS, a key regulatory step controlling nitric oxide and aberrant O2 production, was not different between OZR and LZR. 

Phrase: "The association of heat shock protein 90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with eNOS,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "a key regulatory step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "aberrant O2 production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "not different between OZR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "LZR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.18: Taken together, these results suggest that changes in eNOS expression or posttranslation regulation do not underlie the vascular dysfunction seen with insulin resistance and that other mechanisms, such as altered localization, reduced availability of cofactors, substrates, and the elevated production of O2, may be responsible. syndrome X; 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that changes in eNOS expression"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "posttranslation regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1514251:Post-Translational Regulation [Molecular Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "underlie"

Phrase: "the vascular dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "seen with insulin resistance"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205397:Seen [Qualitative Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "that"

Phrase: "other mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "such as altered localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "reduced availability of cofactors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "the elevated production of O2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "may"

Phrase: "be"

Phrase: "responsible. syndrome X"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206064:syndrome x [Disease or Syndrome]
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.19: Zucker; 

Phrase: "Zucker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700303:Zucker [Mammal]

Phrase: ";"
Processing 00000000.tx.20: obesity INSULIN RESISTANCE, a prediabetic condition associated with obesity, is increasing at an alarming rate in Western cultures (26, 30). 

Phrase: "obesity INSULIN RESISTANCE,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a prediabetic condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "associated with obesity,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "increasing at an alarming rate"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0336648:alarming [Medical Device]
   760   C0442808:Increasing [Functional Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   760   C2945761:alarming [Phenomenon or Process]
   726 E C0442805:Increase [Functional Concept]
   726 E C0542180:ALARM [Mental Process]
   726 E C1706451:Alarm [Medical Device]

Phrase: "in Western cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "(26,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.21: Diabetes increases the incidence of many vasculopathies, including atherosclerosis, microvascular disease, and poor wound healing (44, 47). 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the incidence of many vasculopathies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021149:Incidence [Quantitative Concept]
   760   C0220856:incidence [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "atherosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "microvascular disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "poor wound healing"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C1851789:Poor wound healing [Finding]
   901   C0043240:Wound Healing [Organism Function]
           Healing
   827   C0043250:Wound [Injury or Poisoning]
   827   C0205249:Healing [Functional Concept]
   793 E C0016204:Wind NOS [Sign or Symptom]
   793 E C0043187:Wind [Natural Phenomenon or Process]
   743 E C0021501:wounds [Qualitative Concept]
   743 E C0332797:Wounded [Functional Concept]

Phrase: "(44,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.22: Of even greater concern is the mounting evidence that insulin-resistant states, independent of frank diabetes, also promote vascular dysfunction (43, 52). 

Phrase: "Of even greater concern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699424:Concern [Idea or Concept]

Phrase: "is"

Phrase: "the mounting evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that insulin-resistant states,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0332325:Resistant [Functional Concept]
   827   C1301808:states [Geographic Area]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2827757:RESISTANT [Laboratory or Test Result]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "independent of frank diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "also"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "vascular dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(43,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.23: Thus the effect of insulin resistance on vascular signaling mechanisms is an area of increasing scrutiny. 

Phrase: "Thus"

Phrase: "the effect of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on vascular signaling mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "an area of increasing scrutiny."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
Processing 00000000.tx.24: Insulin-resistant states and diabetes are associated with reduced endothelium-dependent relaxation, and this dysfunction of the endothelium is highly correlated with future cardiovascular events (1, 14, 34, 49). 

Phrase: "Insulin-resistant states"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0332325:Resistant [Functional Concept]
   827   C1301808:states [Geographic Area]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2827757:RESISTANT [Laboratory or Test Result]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "are"

Phrase: "associated with reduced endothelium-dependent relaxation,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0014257:Endothelium [Tissue]
   753   C0035028:Relaxation [Activity]
   753   C0392756:Reduced [Qualitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "this dysfunction of the endothelium"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   762   C0856169:endothelial dysfunction [Disease or Syndrome]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "correlated with future cardiovascular events"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1320716:cardiovascular events [Finding]
   760   C0007226:Cardiovascular [Body System]
   760   C0016884:Future [Temporal Concept]
   760   C0441471:Events [Event]
   760   C1707520:Correlated [Qualitative Concept]
   760   C3541888:Events [Classification]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "14,"

Phrase: "34,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.25: In the obese Zucker rat (OZR), we previously showed that endothelium-dependent relaxation is impaired (14); 

Phrase: "In the obese Zucker rat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "we previously"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that endothelium-dependent relaxation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0014257:Endothelium [Tissue]
   827   C0035028:Relaxation [Activity]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(14"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.26: however, the mechanisms underlying reduced synthesis or action of nitric oxide (NO) remain to be established. 

Phrase: "however,"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "reduced synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "or"

Phrase: "action of nitric oxide (NO)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.27: Endothelium-dependent relaxation is mediated by the synthesis and subsequent diffusion of NO from the endothelium to the underlying smooth muscle (21, 35). 

Phrase: "Endothelium-dependent relaxation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0014257:Endothelium [Tissue]
   827   C0035028:Relaxation [Activity]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "is"

Phrase: "mediated by the synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "subsequent diffusion of NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012222:Diffusion [Natural Phenomenon or Process]
   760   C1696141:Diffusion [Functional Concept]

Phrase: "from the endothelium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelium [Tissue]

Phrase: "to the underlying smooth muscle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "(21,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.28: Of the three NO synthases (NOS), the endothelial isoform (eNOS) is uniquely positioned within the vascular endothelium and alone is responsible for endothelium-dependent NO-mediated relaxation (20). 

Phrase: "Of the three NO synthases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0132555:nitric oxide synthases [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(NOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518425:{NOS} [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the endothelial isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")"

Phrase: "is"

Phrase: "uniquely"

Phrase: "positioned within the vascular endothelium"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0014261:Endothelium, Vascular [Tissue]
   778 E C1706972:Blood Vessel Endothelium [Tissue]
   760   C0005847:vascular [Body Part, Organ, or Organ Component]
   760   C0014257:Endothelium [Tissue]
   760   C1558950:VASCULAR [Finding]
   760   C1801960:Vascular [Qualitative Concept]
   726   C0733755:Position [Spatial Concept]
   704 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   704 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "responsible for endothelium-dependent NO-mediated relaxation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.29: The amount of NO produced in response to a given stimulus is tightly regulated by transcriptional and posttranscriptional events. 

Phrase: "The amount of NO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "produced in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to a given stimulus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimulus [Phenomenon or Process]

Phrase: "is"

Phrase: "tightly"

Phrase: "regulated by transcriptional"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040649:Transcriptional [Genetic Function]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "posttranscriptional events."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]
Processing 00000000.tx.30: Aside from chronic changes in gene expression, the activity of eNOS is acutely regulated by posttranslational modifications, including protein-protein interactions and phosphorylation (16). 

Phrase: "Aside from chronic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "in gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the activity of eNOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1151383:nitric-oxide synthase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "acutely"

Phrase: "regulated by posttranslational modifications,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0033666:Post-Translational Modifications [Molecular Function]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "protein-protein interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.31: In endothelial cells, eNOS is dynamically bound to the molecular chaperone heat shock protein (HSP) 90, caveolin-1, and dynamin-2 and is phosphorylated on serine, threonine, and tyrosine residues in a stimulus-dependent manner (11, 16). 

Phrase: "In endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "dynamically"

Phrase: "bound to the molecular chaperone heat shock protein (HSP) 90,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   818   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone
   764   C0282498:Heat Shock [Physiologic Function]
   762   C0522527:Protein bound [Qualitative Concept]
   742   C0018837:Heat [Natural Phenomenon or Process]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036974:Shock [Pathologic Function]
   742   C0332297:bound [Spatial Concept]
   742   C0439083:>90 [Quantitative Concept]
   742   C0439087:<90 [Quantitative Concept]
   742   C1145667:Bound [Activity]
   742   C1167622:Bound [Molecular Function]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1689898:% bound [Quantitative Concept]
   742   C2349209:Bound [Conceptual Entity]

Phrase: "caveolin-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "dynamin-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0209328:Dynamin 2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1414120:DYNAMIN 2 [Gene or Genome]
   861   C0058836:Dynamin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "is"

Phrase: "phosphorylated on serine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "threonine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "tyrosine residues in a stimulus-dependent manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(11,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.32: The relation between insulin and NO production has been examined in several models, many of which demonstrate that insulin promotes NO-mediated vasodilation and increases the expression of eNOS in cultured cells (6, 28, 39, 46). 

Phrase: "The relation between insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0080103:Relation [Family Group]
   770   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "NO production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "examined in several models,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332128:Examined [Finding]
   770   C3161035:Models [Intellectual Product]

Phrase: "many of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439064:Many [Quantitative Concept]
   790   C0747726:many [Conceptual Entity]

Phrase: "demonstrate"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "NO-mediated vasodilation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0042401:Vasodilation [Physiologic Function]
   812   C0595862:VASODILATION [Pathologic Function]
   812   C3537065:Vasodilation [Physiologic Function]

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of eNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(6,"

Phrase: "28,"

Phrase: "39,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.33: This led to the expectation that insulin-resistant states would be associated with reduced eNOS expression, and, indeed, this has been shown in some studies (28). 

Phrase: "This"

Phrase: "led to the expectation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0679138:Expectation [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that insulin-resistant states"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0332325:Resistant [Functional Concept]
   827   C1301808:states [Geographic Area]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2827757:RESISTANT [Laboratory or Test Result]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "would"

Phrase: "be"

Phrase: "associated with reduced eNOS expression,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   800   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0014257:Endothelial [Tissue]
   744   C0030015:oxide [Inorganic Chemical]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0392756:Reduced [Qualitative Concept]
   744   C2986642:oxide [Chemical Viewed Functionally]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: ","

Phrase: "indeed,"

Phrase: "this"

Phrase: "has"

Phrase: "been"

Phrase: "shown in some studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737   C1547282:Show [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.34: A limitation of previous studies, however, has been that eNOS expression has been evaluated by mRNA levels (Northern blot and PCR). 

Phrase: "A limitation of previous studies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449295:Limitation [Functional Concept]

Phrase: "however,"

Phrase: "has"

Phrase: "been"

Phrase: "that eNOS expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "evaluated by mRNA levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0220825:Evaluated [Functional Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Northern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:Northern Blot [Molecular Biology Research Technique]
  1000   C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "and"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: ")."
Processing 00000000.tx.35: Furthermore, changes in gene expression can only chronically influence the amount of NO produced by endothelial cells, and the impact of the insulin-resistant state on the acute posttranslation regulation of eNOS has yet to be studied. 

Phrase: "Furthermore,"

Phrase: "changes in gene expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0017262:Gene Expression [Genetic Function]
   770   C0017337:Gene [Gene or Genome]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "only chronically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "influence"

Phrase: "the amount of NO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "produced by endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0225336:Endothelial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0014257:Endothelial [Tissue]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the impact of the insulin-resistant state"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "on the acute posttranslation regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C1514251:Post-Translational Regulation [Molecular Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "of eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.36: The goal of the present study was to test the hypothesis that eNOS signaling, as assayed by eNOS expression levels, phosphorylation, and interaction with HSP-90, is reduced in insulin-resistant states. 

Phrase: "The goal of the present study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018017:Goal [Intellectual Product]
   753   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that eNOS signaling,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   888   C1155501:nitric oxide signaling [Molecular Function]
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "assayed by eNOS expression levels,"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   833   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   800   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0014257:Endothelial [Tissue]
   744   C0030015:oxide [Inorganic Chemical]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   744   C2986642:oxide [Chemical Viewed Functionally]
   737   C3244092:expression level [Idea or Concept]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711   C1510438:Assay [Laboratory Procedure]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "interaction with HSP-90,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0872079:interaction protein [Molecular Function]
   753   C1704675:Interaction [Functional Concept]
   716   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "reduced in insulin-resistant states."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0332325:Resistant [Functional Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1301808:states [Geographic Area]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2827757:RESISTANT [Laboratory or Test Result]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.37: Three insulin-resistant animal models were studied: the OZR, the fructose-fed rat, and the ob/ob mouse. 

Phrase: "Three insulin-resistant animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0599779:Models, Animal [Animal]
   804   C0003062:Animal [Animal]
   804   C3161035:Models [Intellectual Product]

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "the OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "the fructose-fed rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "the ob/ob mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
Processing 00000000.tx.38: These models exhibit insulin resistance in its most common context (obesity and leptin resistance in OZR), in the absence of obesity (fructose-fed rat), and in the absence of leptin resistance (ob/ob mouse). 

Phrase: "These models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "insulin resistance in its most common context"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "leptin resistance in OZR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]

Phrase: ")"

Phrase: ","

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(fructose-fed rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "and in the absence of leptin resistance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0237834:Resistance [Mental Process]
   748   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
   748   C0332197:absence [Quantitative Concept]
   748   C1416825:LEPTIN [Gene or Genome]
   748   C1514892:Resistance [Physiologic Function]
   748   C1515981:And [Idea or Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "(ob/ob mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: ")."
Processing 00000000.tx.39: The expression levels of three NOS isoforms were measured: inducible NOS (iNOS), eNOS, and neuronal NOS (nNOS). 

Phrase: "The expression levels of three NOS isoforms"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Levels [Qualitative Concept]
   745   C3244092:expression level [Idea or Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ":"

Phrase: "inducible NOS (iNOS),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "eNOS,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "neuronal NOS (nNOS)."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]
Processing 00000000.tx.40: Three vascular compartments were analyzed: heart, aorta, and hindlimb musculature. 

Phrase: "Three vascular compartments"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   793 E C2986730:Compartment [Spatial Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ":"

Phrase: "heart,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "aorta,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003483:Aorta [Body Part, Organ, or Organ Component]
  1000   C1278934:Aorta [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "hindlimb musculature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1995013:Musculature [Body Part, Organ, or Organ Component]
Processing 00000000.tx.41: The acute regulation of eNOS was monitored through association with HSP-90 and protein phosphorylation of T494, S632, and S1176. 

Phrase: "The acute regulation of eNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "was"

Phrase: "monitored through association"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "with HSP-90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "protein phosphorylation of T494,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   770   C0031715:Phosphorylation [Molecular Function]

Phrase: "S632,"

Phrase: "and"

Phrase: "S1176."
Processing 00000000.tx.42: Finally, an in vitro model of insulin resistance was induced in endothelial cells via adenoviral expression of protein tyrosine phosphatase (PTP) 1B (51). 

Phrase: "Finally,"

Phrase: "an in vitro model of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1515654:In Vitro Model [Research Activity]
   748   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "induced in endothelial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0225336:Endothelial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0014257:Endothelial [Tissue]
   770   C0205263:Induced [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "via adenoviral expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of protein tyrosine phosphatase (PTP) 1B"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.43: Regardless of the model, eNOS expression, phosphorylation, or binding to HSP-90 was undiminished. 

Phrase: "Regardless of the model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "eNOS expression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "binding to HSP-90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   864   C1523546:heat shock protein binding [Molecular Function]
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   716   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "undiminished."
Processing 00000000.tx.44: Collateral changes in iNOS or nNOS were also not observed. 

Phrase: "Collateral changes in iNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "were"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.45: Taken together, these data provide compelling evidence that aberrations in the expression, protein-protein interactions, and phosphorylation of eNOS are not a major defect in insulin-resistant states. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "compelling evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that aberrations in the expression,"

Phrase: "protein-protein interactions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "phosphorylation of eNOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a major defect in insulin-resistant states."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.46: These findings suggest that frank diabetes, with the complete loss of insulin, may be required to reduce NOS expression and that the impairments of NO-mediated responses in insulin-resistant states may reflect conditions of altered NO bioavailability or alterations in the target pathways for NO.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that frank diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "with the complete loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "of insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "NOS expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "that"

Phrase: "the impairments of NO-mediated responses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0684336:Impairments [Pathologic Function]
   748   C2598156:Impairments [Clinical Attribute]

Phrase: "in insulin-resistant states"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0332325:Resistant [Functional Concept]
   827   C1301808:states [Geographic Area]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2827757:RESISTANT [Laboratory or Test Result]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "conditions of altered NO bioavailability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "or"

Phrase: "alterations in the target pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "for NO."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.47: MATERIALS AND METHODS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Animal models. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animal models."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.48: All animals were used in accordance with the guidelines for animal use of the Institutional Animal Care and Use Committee of the Medical College of Georgia, an American Association of Laboratory Animal Care-accredited animal facility. 

Phrase: "All animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "used in accordance with the guidelines"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0162791:Guidelines [Intellectual Product]
   753   C0220845:guidelines [Intellectual Product]
   753   C0282423:guidelines [Intellectual Product]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "for animal use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0042153:use [Functional Concept]
   861   C0457083:Use [Functional Concept]
   861   C1947944:Use [Intellectual Product]

Phrase: "of the Institutional Animal Care"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0868975:Institutional care [Health Care Activity]
   901   C0178478:animal care [Occupation or Discipline]
   827   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee of the Medical College of Georgia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2699414:Committee [Group]

Phrase: "an American Association of Laboratory Animal Care-accredited animal facility."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]
Processing 00000000.tx.49: Lean Zucker rats (LZR) and OZR were obtained from Harlan (Indianapolis, IN) at 6 wk of age and maintained on standard chow ad libitum until they were used for study. 

Phrase: "Lean Zucker rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: ")"

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "were"

Phrase: "obtained from Harlan"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Indianapolis,"

Phrase: "IN) at 6 wk of age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]

Phrase: "and"

Phrase: "maintained on standard chow"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0324335:chow [Mammal]
   770   C1314677:Maintained [Functional Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]
   737 E C0024501:Maintain [Activity]

Phrase: "ad libitum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]

Phrase: "until"

Phrase: "they"

Phrase: "were"

Phrase: "used for study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   841   C0869040:study use [Research Activity]
   790   C0557651:Study [Manufactured Object]
   790   C1273517:used [Finding]
   790   C2603343:Study [Research Activity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: OZR (fa/fa) possess a missense mutation in the leptin receptor (G269P) (48) that renders the receptor dysfunctional (5). 

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(fa/fa)"

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "a missense mutation in the leptin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0599155:Missense Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(G269P"

Phrase: ")"

Phrase: "(48"

Phrase: ")"

Phrase: "that"

Phrase: "renders"

Phrase: "the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "dysfunctional"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   928   C0031847:dysfunction [Functional Concept]
   928   C0277785:Dysfunction, NOS [Qualitative Concept]
   907 E C0231174:Malfunction [Functional Concept]
   907 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.51: The fa is an autosomal recessive locus, and heterozygotes (LZR) do not express the fa phenotype. 

Phrase: "The fa"

Phrase: "is"

Phrase: "an autosomal recessive locus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708726:Locus [Gene or Genome]
   734   C0441748:Autosomal recessive [Intellectual Product]

Phrase: "and"

Phrase: "heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "(LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: ")"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "the fa phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.52: On the day of death, each animal was sedated with isoflurane anesthesia. 

Phrase: "On the day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "of death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "each animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "was"

Phrase: "sedated with isoflurane anesthesia."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   770   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   770   C0022180:Isoflurane [Organic Chemical,Pharmacologic Substance]
   770   C0235195:Sedated [Finding]
Processing 00000000.tx.53: A catheter was inserted into the jugular vein, and a glucose tolerance test was performed by measuring the clearance of a 60-mg glucose bolus over 30 min. 

Phrase: "A catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085590:Catheter [Medical Device]
  1000   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "inserted into the jugular vein,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0022427:Jugular vein [Body Part, Organ, or Organ Component]
   806   C1280188:Jugular vein [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0441587:Inserted [Health Care Activity]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "a glucose tolerance test"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0017741:Glucose tolerance test [Diagnostic Procedure]
   913   C0337438:glucose test [Laboratory Procedure]
   913   C0595310:GLUCOSE TEST [Medical Device]
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0201777:Tolerance test [Laboratory Procedure]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0392366:test [Intellectual Product]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "was"

Phrase: "performed by measuring"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the clearance of a 60-mg glucose bolus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C3272933:Glucose Clearance [Laboratory Procedure]
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "over 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.54: Plasma samples were acquired for plasma cholesterol, triglyceride, and insulin. 

Phrase: "Plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444263:Plasma sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "acquired for plasma cholesterol,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0858034:plasma cholesterol [Laboratory Procedure]
   773   C3276464:Increased cholesterol [Finding]
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   770   C0032105:Plasma [Body Substance]
   770   C0439661:Acquired [Temporal Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C3245488:acquired [Intellectual Product]
   737 E C1706701:Acquire [Activity]

Phrase: "triglyceride,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041004:Triglyceride [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.55: Animals were then killed with an overdose of pentobarbital sodium anesthesia (75 mg/kg), and the heart, aorta, and a portion of hindlimb skeletal muscle were quickly removed and snap frozen in liquid nitrogen. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "killed with an overdose of pentobarbital sodium anesthesia"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0700349:Pentobarbital Sodium [Organic Chemical,Pharmacologic Substance]
   744   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   744   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   744   C0029944:Overdose [Injury or Poisoning]
   744   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0162388:killed [Social Behavior]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1546941:Overdose [Idea or Concept]
   711 E C0681205:Kill [Idea or Concept]
   711 E C1550555:kill [Functional Concept]

Phrase: "(75 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the heart,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "aorta,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003483:Aorta [Body Part, Organ, or Organ Component]
  1000   C1278934:Aorta [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "a portion of hindlimb skeletal muscle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "were"

Phrase: "quickly"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "snap"

Phrase: "frozen in liquid nitrogen."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
Processing 00000000.tx.56: To reduce the confounding influence of obesity in leptin-resistant animals, young, minimally obese Zucker rats were also studied. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "the confounding influence of obesity"

Phrase: "in leptin-resistant animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "minimally obese Zucker rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0034719:Rats, Zucker [Mammal]
   812   C0028754:Obese [Disease or Syndrome]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C2700303:Zucker [Mammal]

Phrase: "were"

Phrase: "also"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.57: Insulin resistance independent of obesity was modeled by feeding a 66% fructose diet (Harlan Teklad) to LZR for 8 wk (33). 

Phrase: "Insulin resistance independent of obesity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "modeled by feeding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0204695:Feeding [Health Care Activity]
   790   C2987508:Feeding [Activity]
   756   C3161035:Model [Intellectual Product]

Phrase: "a 66% fructose diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "(Harlan Teklad"

Phrase: ")"

Phrase: "to LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "for 8 wk (33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332174:/wk [Temporal Concept]
   827   C0439230:wk [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.58: Insulin resistance independent of leptin resistance was modeled using ob/ob mice (Jackson Laboratories) and tissue samples (a generous gift from Mark Hamrick, Medical College of Georgia). 

Phrase: "Insulin resistance independent of leptin resistance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "was"

Phrase: "modeled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3161035:Model [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ob/ob mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Jackson Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "tissue samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1292533:Tissue Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "a generous gift from Mark Hamrick,"

Phrase: "Medical College of Georgia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.59: Plasma analysis. 

Phrase: "Plasma analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.60: Plasma glucose was measured with a standard glucometer (Precision Xtra) and expressed as milligrams per deciliter. 

Phrase: "Plasma glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0202042:Plasma glucose [Laboratory Procedure]
  1000   C0455280:plasma glucose [Laboratory or Test Result]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "was"

Phrase: "measured with a standard glucometer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0444706:Measured [Qualitative Concept]
   760   C0472226:Glucometer [Medical Device]
   760   C1442989:Standard [Qualitative Concept]
   760   C2828392:Standard [Intellectual Product]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(Precision Xtra"

Phrase: ")"

Phrase: "and"

Phrase: "expressed as milligrams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439210:milligrams [Quantitative Concept]

Phrase: "per deciliter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439241:deciliter [Quantitative Concept]
Processing 00000000.tx.61: Plasma total cholesterol and triglycerides were measured by individual kits (WakoUSA, Richmond, VA). 

Phrase: "Plasma total cholesterol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0858034:plasma cholesterol [Laboratory Procedure]
   901   C0201950:Total Cholesterol [Laboratory Procedure]
   901   C0543421:Total cholesterol [Steroid]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "triglycerides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041004:Triglycerides [Biologically Active Substance,Lipid]

Phrase: "were"

Phrase: "measured by individual kits"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   770   C0027361:Individual [Population Group]
   770   C0237401:Individual [Human]
   770   C0444706:Measured [Qualitative Concept]
   770   C1690540:Kits [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C0812225:KIT [Medical Device]
   737 E C1150635:KIT [Molecular Function]
   737 E C1705212:Kit [Medical Device]
   737 E C1705213:KIT [Medical Device]
   737 E C3273202:Kit [Manufactured Object]

Phrase: "(WakoUSA,"

Phrase: "Richmond,"

Phrase: "VA)."
Processing 00000000.tx.62: Rat plasma insulin was assayed by rat-specific enzyme immunoassay (Alpco, Windham, NH). 

Phrase: "Rat plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "assayed by rat-specific enzyme immunoassay"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0086231:Enzyme Immunoassay [Laboratory Procedure]
   767   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0020980:Immunoassay [Laboratory Procedure]
   753   C0021060:immunoassay [Laboratory Procedure]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "(Alpco,"

Phrase: "Windham,"

Phrase: "NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.63: Plasma NOx (NO2 + NO3) levels were determined by NO-specific chemiluminescence, as described previously (15). 

Phrase: "Plasma NOx"

Phrase: "(NO2 + NO3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919442:NO3 [Gene or Genome]
   861   C1705347:NO3 [Gene or Genome]

Phrase: ")"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by NO-specific chemiluminescence,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   753   C0205369:Specific [Qualitative Concept]
   753   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   753   C1552740:specific [Intellectual Product]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.64: Briefly, plasma proteins were precipitated with ethanol, and NO3 was quantitatively reduced to NO2 with nitrate reductase. 

Phrase: "Briefly,"

Phrase: "plasma proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "were"

Phrase: "precipitated with ethanol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001962:Ethanol [Organic Chemical]
   756   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "NO3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919442:NO3 [Gene or Genome]
  1000   C1705347:NO3 [Gene or Genome]

Phrase: "was"

Phrase: "quantitatively"

Phrase: "reduced to NO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "with nitrate reductase."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028123:nitrate reductase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0068800:nitrate reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0028125:Nitrate [Chemical Viewed Structurally]
   861   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0699857:Nitrate [Inorganic Chemical]
   761 E C1328815:nitration [Phenomenon or Process]
Processing 00000000.tx.65: NO2 was then measured from plasma samples and endothelial cell media via conversion to NO in an NO analyzer (model 280i, Ionics Instruments, Boulder, CO). 

Phrase: "NO2"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "measured from plasma samples"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0449770:Measured from [Quantitative Concept]
   816   C0444263:Plasma sample [Body Substance]
   786   C2348149:Sample Measure [Quantitative Concept]
   770   C0032105:Plasma [Body Substance]
   770   C0444706:Measured [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "endothelial cell media via conversion"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "to NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in an NO analyzer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0494017:ANALYZER, NITRIC OXIDE [Medical Device]
   827   C0179038:Analyzer [Medical Device]
   827   C1706246:Analyzer [Manufactured Object]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "(model 280i,"

Phrase: "Ionics Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Boulder,"

Phrase: "CO"

Phrase: ")."
Processing 00000000.tx.66: Determination of endothelium-dependent vasodilation. 

Phrase: "Determination of endothelium-dependent vasodilation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.67: Endothelium-dependent vasodilation was assessed using the isolated gracilis artery preparation, as described previously (14). 

Phrase: "Endothelium-dependent vasodilation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0042401:Vasodilation [Physiologic Function]
   827   C0595862:VASODILATION [Pathologic Function]
   827   C3537065:Vasodilation [Physiologic Function]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the isolated gracilis artery preparation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0455052:Preparation [Health Care Activity]
   812   C1521827:Preparation [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.68: Briefly, gracilis arteries were isolated from the hindlimb of LZR and OZR, mounted between two glass pipettes, and pressurized at 60 mmHg. 

Phrase: "Briefly,"

Phrase: "gracilis arteries"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0003842:Arteries [Body Part, Organ, or Organ Component]
   861   C0226004:arteries [Body System]
   777 E C0221464:Arterial [Spatial Concept]

Phrase: "were"

Phrase: "isolated from the hindlimb of LZR"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0034719:Rats, Zucker [Mammal]
   744   C0023216:Hindlimb, NOS [Body Location or Region]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C1269079:Hind limb [Body Part, Organ, or Organ Component]
   744   C1456800:Hindlimb [Body Part, Organ, or Organ Component]
   744   C1522391:Hindlimb [Body Part, Organ, or Organ Component]
   744   C1548221:Isolated [Idea or Concept]
   744   C2700303:Zucker [Mammal]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "mounted between two glass pipettes,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0017596:Glass [Manufactured Object]
   760   C0182301:pipettes [Medical Device]
   760   C0205448:Two [Quantitative Concept]
   760   C0449878:mounted [Finding]
   760   C1947936:Glass [Medical Device]
   726 E C0181909:Mount [Medical Device]
   726 E C1706407:Pipette [Medical Device]

Phrase: "and"

Phrase: "pressurized at 60 mmHg."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439475:mmHg [Quantitative Concept]
Processing 00000000.tx.69: Vessels generated 1520% baseline tone, which was further increased with 106 M phenylephrine to a final diameter that was 50% of passive diameter. 

Phrase: "Vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "1520% baseline tone,"

Phrase: "which"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "increased with 106 M phenylephrine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0626189:M 106 [Organic Chemical,Pharmacologic Substance]
   760   C0031469:Phenylephrine [Organic Chemical,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0442805:Increased [Functional Concept]

Phrase: "to a final diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1301886:Diameter [Quantitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "50% of passive diameter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1301886:Diameter [Quantitative Concept]
Processing 00000000.tx.70: Endothelium-dependent vasodilation to acetylcholine is 100% sensitive to nitro-L-arginine methyl ester in this preparation (14) and was used as an index of NO-mediated dilation. 

Phrase: "Endothelium-dependent vasodilation to acetylcholine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0042401:Vasodilation [Physiologic Function]
   760   C0595862:VASODILATION [Pathologic Function]
   760   C3537065:Vasodilation [Physiologic Function]

Phrase: "is"

Phrase: "100% sensitive to nitro-L-arginine methyl ester"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332324:Sensitive to [Functional Concept]
           Sensitive
   744   C1550474:sensitive [Idea or Concept]

Phrase: "in this preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "used as an index of NO-mediated dilation."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   745   C1524063:Use of [Functional Concept]
   742   C0012359:Dilation [Pathologic Function]
   742   C0030015:oxide [Inorganic Chemical]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0393293:Dilation [Therapeutic or Preventive Procedure]
   742   C0700124:Dilation [Functional Concept]
   742   C0918012:Index [Intellectual Product]
   742   C1273517:used [Finding]
   742   C1552854:index [Idea or Concept]
   742   C1637833:% index [Quantitative Concept]
   742   C2986642:oxide [Chemical Viewed Functionally]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.71: Serial doses of acetylcholine from 107 to 3 x 105 M were applied to the bath, and diameter was recorded during steady-state conditions. 

Phrase: "Serial doses of acetylcholine"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0178602:Doses [Quantitative Concept]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "from 107"

Phrase: "to 3 x 105 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "were"

Phrase: "applied to the bath,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0150141:Bath [Therapeutic or Preventive Procedure]
   770   C0185125:Applied [Health Care Activity]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301886:Diameter [Quantitative Concept]

Phrase: "was"

Phrase: "recorded during steady-state conditions."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0678587:steady state [Natural Phenomenon or Process]
   760   C0205361:Steady [Qualitative Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]
   726   C0012634:condition [Disease or Syndrome]
   726   C0034869:Record [Intellectual Product]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.72: Data are expressed as percent increase in preconstricted diameter. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percent increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439165:Percent [Quantitative Concept]
   770   C0442805:Increase [Functional Concept]

Phrase: "in preconstricted diameter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1301886:Diameter [Quantitative Concept]
Processing 00000000.tx.73: Western blotting. 

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.74: Blood vessels and tissue samples were snap frozen in liquid nitrogen immediately after extraction and pulverized as described previously. 

Phrase: "Blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "tissue samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1292533:Tissue Sample [Tissue]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "snap"

Phrase: "frozen in liquid nitrogen immediately"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   806   C1550121:Liquid nitrogen [Intellectual Product]
   760   C0016701:Frozen [Natural Phenomenon or Process]
   760   C0028158:Nitrogen [Element, Ion, or Isotope]
   760   C0205548:Immediately [Temporal Concept]
   760   C0302908:Liquid [Substance]
   760   C0677542:Frozen [Functional Concept]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1550581:nitrogen [Human-caused Phenomenon or Process]
   760   C1561501:Liquid NOS [Substance]

Phrase: "after"

Phrase: "extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185115:Extraction [Therapeutic or Preventive Procedure]
  1000   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "pulverized"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously."
Processing 00000000.tx.75: Proteins were solubilized in a lysis buffer containing 1% Nonidet P-40, 0.1% SDS, 0.1% deoxycholate, 50 mM TrisHCl, 0.1 mM EGTA, 0.1 mM EDTA, 5 mM sodium fluoride, 1 mM sodium pyrophosphate, 1 mM sodium vanadate, 1 mmol 4-(2-aminoethyl)-benzenesulfonyl fluoride, and a protease inhibitor cocktail tablet (Roche Diagnostics, Mannheim, Germany), pH 7.5. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "solubilized in a lysis buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:Lysis [Pathologic Function]
   760   C1536403:lysis [Cell Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "0.1% SDS,"

Phrase: "0.1% deoxycholate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]

Phrase: "50 mM TrisHCl,"

Phrase: "0.1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "5 mM sodium fluoride,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0037508:Sodium Fluoride [Biomedical or Dental Material,Inorganic Chemical]
   861   C1171560:sodium fluoride [Pharmacologic Substance]
   861   C1556062:Sodium Fluoride [Intellectual Product]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   805 E C0721463:Luride [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM sodium pyrophosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0074764:sodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mM sodium vanadate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037568:Sodium Vanadate [Inorganic Chemical,Pharmacologic Substance]
   812   C0042305:Vanadate [Inorganic Chemical]

Phrase: "1 mmol 4-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439190:MMOLE [Quantitative Concept]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "(2-aminoethyl"

Phrase: ")-"

Phrase: "benzenesulfonyl fluoride,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "a protease inhibitor cocktail tablet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0039225:Tablet [Biomedical or Dental Material]
   812   C1705223:Tablet [Quantitative Concept]

Phrase: "(Roche Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "pH 7.5."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.76: Insoluble protein was removed by centrifugation, and protein content in the supernatants was quantified using the Lowry method with bovine serum albumin as the standard. 

Phrase: "Insoluble protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "removed by centrifugation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "protein content in the supernatants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Lowry method with bovine serum albumin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "as the standard."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.77: For detection of phosphorylated eNOS species, eNOS was affinity purified from cell lysates using 2',5'-ADP-Sepharose (Pharmacia). 

Phrase: "For detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of phosphorylated eNOS species,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1705920:Species [Conceptual Entity]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C1881488:Cell Lysate [Physical Object]
           Lysate
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C1998793:Purified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5'-ADP-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Sepharose [Carbohydrate]

Phrase: "(Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.78: Proteins were size fractionated by SDS-PAGE and immunoblotted with antibodies to eNOS (BD Biosciences); 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "fractionated by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   770   C1979893:Fractionated [Qualitative Concept]

Phrase: "and"

Phrase: "immunoblotted with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756   C0020985:Immunoblot [Laboratory Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(BD Biosciences"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.79: phosphorylated eNOS (S1179; Zymed laboratories); 

Phrase: "phosphorylated eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   884   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0014257:Endothelial [Tissue]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(S1179"

Phrase: "; Zymed laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.80: T497 (Upstate); 

Phrase: "T497"

Phrase: "(Upstate"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.81: S635 (Bruce Kemp, Melbourne, Australia); 

Phrase: "S635"

Phrase: "(Bruce Kemp,"

Phrase: "Melbourne,"

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.82: iNOS, nNOS, insulin receptor (IR), PTP-1B, and HSP-90 (BD Biosciences); 

Phrase: "iNOS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "nNOS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "insulin receptor (IR),"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "PTP-1B,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "and"

Phrase: "HSP-90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "(BD Biosciences"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.83: phosphorylated Akt (Cell Signaling); 

Phrase: "phosphorylated Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "(Cell Signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Cell Signaling [Cell Function]
           Signaling
   861   C3537152:signaling [Biologic Function]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.84: and phosphorylated IR (Biosource). 

Phrase: "and"

Phrase: "phosphorylated IR"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Biosource"

Phrase: ")."
Processing 00000000.tx.85: The intensities of the bands corresponding to the proteins of interest were measured using densitometry. 

Phrase: "The intensities of the bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:intensities [Qualitative Concept]

Phrase: "corresponding to the proteins of interest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0543488:Interest [Mental Process]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.86: To assess interactions between eNOS and HSP-90, cell lysates were precleared with protein A/G-agarose (sc-2003, Santa Cruz Biotechnology). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "interactions between eNOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1704675:Interaction [Functional Concept]
   716   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "and"

Phrase: "HSP-90,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "precleared with protein A/G-agarose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0060916:protein g [Amino Acid, Peptide, or Protein]
   783   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036681:Agarose [Carbohydrate]
   753   C0439267:g% [Quantitative Concept]

Phrase: "(sc-2003,"

Phrase: "Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.87: Anti-eNOS (N30020 [GenBank] , Transduction Laboratories) was incubated overnight at 4C. 

Phrase: "Anti-eNOS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   884   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(N30020"

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "] ,"

Phrase: "Transduction Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]
Processing 00000000.tx.88: Protein A/G-agarose was subsequently added, and samples were incubated for an additional 3 h at 4C. 

Phrase: "Protein A/G-agarose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0036681:Agarose [Carbohydrate]
   708   C0060916:protein g [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "subsequently"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated for an additional 3 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0041119:h 3 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1524062:Additional [Functional Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.89: Immunoprecipitated proteins bound to the agarose beads were washed twice, and the samples were boiled in SDS sample buffer to elute the proteins from the beads. 

Phrase: "Immunoprecipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bound to the agarose beads"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0036681:Agarose [Carbohydrate]
   760   C0332297:bound [Spatial Concept]
   760   C0991566:Beads [Biomedical or Dental Material]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "boiled in SDS sample buffer to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]
   719   C0242301:Boil [Disease or Syndrome]
   719   C1546559:Boil [Intellectual Product]

Phrase: "elute"

Phrase: "the proteins from the beads."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.90: Agarose beads were pelleted by centrifugation, and protein supernatants were used for immunoblotting as described above. 

Phrase: "Agarose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "pelleted by centrifugation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "protein supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used for immunoblotting"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "as described above."
Processing 00000000.tx.91: Cell culture. 

Phrase: "Cell culture."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.92: Bovine aortic endothelial cells (BAECs, passage 24) were cultured in medium 199 containing 10% (vol/vol) iron-supplemented FCS, 5% (vol/vol) FCS, 100 IU/ml penicillin, and 100 g/ml streptomycin. 

Phrase: "Bovine aortic endothelial cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0225336:Endothelial Cells [Cell]
   812   C0003483:Aortic [Body Part, Organ, or Organ Component]
   812   C0007452:Bovine [Mammal]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C1140701:bovine [Mammal]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(BAECs,"

Phrase: "passage 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "in medium 199"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0009458:Medium [Intellectual Product]
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10%"

Phrase: "(vol/vol) iron-supplemented FCS,"

Phrase: "5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(vol/vol) FCS,"

Phrase: "100 IU/ml penicillin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]
   756   C2346524:100 IU/mL [Quantitative Concept]

Phrase: "and"

Phrase: "100 g/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.93: NO release from endothelial cells was determined as previously described (15). 

Phrase: "NO release from endothelial cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined as previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.94: Real-time PCR. 

Phrase: "Real-time PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]
Processing 00000000.tx.95: Real-time RT-PCR was performed using the SmartCycler system (Cepheid). 

Phrase: "Real-time RT-PCR"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   861   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C1550177:Real Time [Idea or Concept]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0040223:Time [Temporal Concept]
   812   C0237400:Real [Qualitative Concept]
   812   C0677874:pCR [Finding]
   812   C3272377:REAL [Intellectual Product]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SmartCycler system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Cepheid"

Phrase: ")."
Processing 00000000.tx.96: Plasmids containing fragments of rat eNOS (accession no. AF085195), HSP-90 (S45392 [GenBank] ), and Tie2 (AF030423 [GenBank] ) were generated via RT-PCR of total RNA from rat heart as described below and cloned into pcDNA3 (Invitrogen). 

Phrase: "Plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "fragments of rat eNOS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   731   C1565682:endothelial nitric oxide synthase, rat [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "(accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510755:Accession [Intellectual Product]
  1000   C1706078:Accession [Activity]

Phrase: "no. AF085195"

Phrase: ")"

Phrase: ","

Phrase: "HSP-90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "(S45392"

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Tie2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1336602:TIE2 [Gene or Genome]
  1000   C1705001:TIE2 [Gene or Genome]

Phrase: "(AF030423"

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: "were"

Phrase: "generated via RT-PCR of total RNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C3146294:Generated [Activity]

Phrase: "from rat heart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "described below"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "cloned into pcDNA3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0009013:cloned [Cell]
   756 E C1522642:Clone [Tissue]

Phrase: "("

Phrase: "Invitrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0916178:trizol [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.97: Primers were as follows: 5'-agcccgggacttcatcaatcag-3' (sense) and 5'-gccccaaacaccagctcactctc-3' (antisense) for eNOS, 5'-aggcccaaaacccactcca-3' (sense) and 5'-ggcatcctcatcaccctccag-3' (antisense) for HSP-90, and 5'-cgtgctattggcgtttctgatt-3' (sense) and 5'-gattgtttttggccttcctgttta-3' (antisense) for Tie2. 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "5'-agcccgggacttcatcaatcag-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-gccccaaacaccagctcactctc-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: "for eNOS,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "5'-aggcccaaaacccactcca-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-ggcatcctcatcaccctccag-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: "for HSP-90,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-cgtgctattggcgtttctgatt-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-gattgtttttggccttcctgttta-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: "for Tie2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1336602:TIE2 [Gene or Genome]
  1000   C1705001:TIE2 [Gene or Genome]
Processing 00000000.tx.98: Total RNA (500 ng) was reversed transcribed (Superscript II, Invitrogen), and 10% of the reaction mix was combined with Omnimix Taq reagent (Cepheid), primers, and SYBR-green intercalating fluorescent dye. 

Phrase: "Total RNA (500 ng)"

Phrase: "was"

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed"

Phrase: "(Superscript II,"

Phrase: "Invitrogen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0916178:trizol [Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "10% of the reaction mix"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205430:Mix [Functional Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1421951:MIX [Gene or Genome]
   760   C1720722:Mix [Qualitative Concept]

Phrase: "was"

Phrase: "combined with Omnimix Taq reagent"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   760   C0205195:Combined [Qualitative Concept]
   726 E C0336789:Combine [Manufactured Object]

Phrase: "(Cepheid"

Phrase: ")"

Phrase: ","

Phrase: "primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "SYBR-green intercalating fluorescent dye."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   804   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.99: The PCR cycle was as follows: denaturation at 94C for 15 s, annealing at 55C for 30 s, and extension at 72C for 10 s, with optics turned on. 

Phrase: "The PCR cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511572:Cycle [Temporal Concept]

Phrase: "was"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "denaturation at 94C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0301642:Denaturation [Molecular Function]

Phrase: "for 15 s,"

Phrase: "annealing at 55C"

Phrase: "for 30 s,"

Phrase: "and"

Phrase: "extension at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231448:Extension [Functional Concept]
   790   C1880641:Extension [Conceptual Entity]

Phrase: "for 10 s,"

Phrase: "with optics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0029144:Optics [Occupation or Discipline]
   966 E C0015392:Optic [Body Part, Organ, or Organ Component]

Phrase: "turned on."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0541749:turned [Finding]
   799 E C1709743:Turn [Spatial Concept]
Processing 00000000.tx.100: The SmartCycler system quantifies the degree of fluorescence generated by the accumulating SYBR-green with each cycle of PCR. 

Phrase: "The SmartCycler system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "quantifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the degree of fluorescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "generated by the accumulating SYBR-green"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332583:Green [Qualitative Concept]
   753   C3146294:Generated [Activity]

Phrase: "with each cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]

Phrase: "of PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]
Processing 00000000.tx.101: The cycle threshold (Ct) was the number of PCR cycles required for the fluorescent signal to rise above background. 

Phrase: "The cycle threshold (Ct)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "was"

Phrase: "the number of PCR cycles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "required for the fluorescent signal to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1514873:Required [Functional Concept]
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "rise"

Phrase: "above background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.102: Standard curves were generated from predetermined concentrations of control plasmids, and comparative assessment of Ct from samples run in parallel was used to determine the relative abundance of each gene. 

Phrase: "Standard curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "generated from predetermined concentrations of control plasmids,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086045:Concentrations [Mental Process]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3146294:Generated [Activity]
   748   C3274648:Control [Qualitative Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "comparative assessment of Ct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "from samples run in parallel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2348042:Parallel [Qualitative Concept]
   812   C2826345:PARALLEL [Research Activity]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the relative abundance of each gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346714:Abundance [Qualitative Concept]
Processing 00000000.tx.103: RNA isolation. 

Phrase: "RNA isolation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]
Processing 00000000.tx.104: Frozen tissue was pulverized in a mortar and pestle cooled in liquid nitrogen. 

Phrase: "Frozen tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "pulverized in a mortar"

Phrase: "and"

Phrase: "pestle"

Phrase: "cooled in liquid nitrogen."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
   737   C1548792:Cool [Qualitative Concept]
Processing 00000000.tx.105: The resulting homogenate, still frozen, was immersed in TRIzol reagent (Invitrogen) and homogenized with a Polytron homogenizer. 

Phrase: "The resulting homogenate,"

Phrase: "still"

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: ","

Phrase: "was"

Phrase: "immersed in TRIzol reagent (Invitrogen)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0916178:trizol [Organic Chemical]

Phrase: "and"

Phrase: "homogenized with a Polytron homogenizer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.106: RNA was isolated by 100% isopropanol precipitation and washed twice with 75% ethanol. 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated by 100% isopropanol precipitation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0022237:Isopropanol [Organic Chemical,Pharmacologic Substance]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with 75% ethanol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001962:Ethanol [Organic Chemical]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.107: Quantification of RNA was performed by spectrophotometry, and purity and integrity of 16S and 28S ribosomal RNA was assessed by minigel electrophoresis. 

Phrase: "Quantification of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantification [Quantitative Concept]

Phrase: "was"

Phrase: "performed by spectrophotometry,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0037805:Spectrophotometry [Laboratory Procedure]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "purity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882508:Purity [Quantitative Concept]
   928 E C2247561:PurE [Molecular Function]

Phrase: "and"

Phrase: "integrity of 16S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205266:integrity [Qualitative Concept]
   790   C0872403:integrity [Individual Behavior]
   790   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "28S ribosomal RNA"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0035705:RNA, Ribosomal, 28S [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           28S RNA
   901   C0035701:Ribosomal RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C1622954:ribosomal RNA [Cell Component]
   827   C0035553:Ribosomal [Cell Component]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: "was"

Phrase: "assessed by minigel electrophoresis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013855:Electrophoresis [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
Processing 00000000.tx.108: RNA (500 ng) was reverse transcribed with a commercial RT kit (Superscript II), and resultant cDNA was used for real-time RT-PCR or generation of plasmids containing eNOS, HSP-90, and Tie2 fragments, as described above. 

Phrase: "RNA (500 ng)"

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed with a commercial RT kit (Superscript II"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0680536:commercial [Intellectual Product]
   744   C0812225:KIT [Medical Device]
   744   C1150635:KIT [Molecular Function]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C2825228:Superscript [Intellectual Product]
   744   C3272563:Commercial [Intellectual Product]
   744   C3273202:Kit [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "resultant cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used for real-time RT-PCR"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   820   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   790   C1550177:Real Time [Idea or Concept]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0040223:Time [Temporal Concept]
   753   C0237400:Real [Qualitative Concept]
   753   C0677874:pCR [Finding]
   753   C1273517:used [Finding]
   753   C3272377:REAL [Intellectual Product]
   753   C3541383:Time [Temporal Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "generation of plasmids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079411:Generation [Temporal Concept]
   790   C3146294:Generation [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "eNOS,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "HSP-90,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "Tie2 fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "as"

Phrase: "described above."
Processing 00000000.tx.109: Generation of PTP-1B adenovirus. 

Phrase: "Generation of PTP-1B adenovirus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]
Processing 00000000.tx.110: The gene encoding PTP-1B was isolated from human umbilical vein endothelial cells by RT-PCR. 

Phrase: "The gene encoding PTP-1B"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   839   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0450345:1B [Intellectual Product]
   799   C1149880:phosphatase [Molecular Function]

Phrase: "was"

Phrase: "isolated from human umbilical vein endothelial cells"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   897   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   778   C0041637:Umbilical vein [Embryonic Structure]
   778   C0221313:Umbilical vein [Embryonic Structure]
   778   C0225336:Endothelial Cells [Cell]
   778   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C0014257:Endothelial [Tissue]
   748   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   748   C0042449:Vein [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0205409:Isolated [Functional Concept]
   748   C1278960:Vein [Body Part, Organ, or Organ Component]
   748   C1548221:Isolated [Idea or Concept]
   748   C3282337:Cells [Cell]
   743   C1179027:Vein Endothelium [Tissue]
   714 E C0370215:Isolate [Substance]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "by RT-PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
Processing 00000000.tx.111: Briefly, total RNA was extracted from human umbilical vein endothelial cells using TRIzol. 

Phrase: "Briefly,"

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from human umbilical vein endothelial cells"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   897   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   778   C0041637:Umbilical vein [Embryonic Structure]
   778   C0221313:Umbilical vein [Embryonic Structure]
   778   C0225336:Endothelial Cells [Cell]
   778   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C0014257:Endothelial [Tissue]
   748   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   748   C0042449:Vein [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C1278960:Vein [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   748   C3541890:EXTRACTED [Finding]
   743   C1179027:Vein Endothelium [Tissue]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]
Processing 00000000.tx.112: cDNA was synthesized from oligo(dT)-primed total RNA (1 g) using Superscript II. 

Phrase: "cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "synthesized from oligo(dT)-primed total RNA (1 g)"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0069417:oligo (dT) [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0069423:oligo(G) [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   742   C0028953:Oligo [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0045143:oligo [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   742   C0439175:% total [Quantitative Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0871133:primed [Functional Concept]
   742   C1883254:Synthesized [Activity]
   742   C3539739:DT [Gene or Genome]
   742   C3542920:DT [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Superscript II."
Processing 00000000.tx.113: The 1.3-kb gene for PTP-1B was amplified using primers [accession no. 

Phrase: "The 1.3-kb gene for PTP-1B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1335554:Protein Tyrosine Phosphatase Gene [Gene or Genome]
   775   C1335547:Protein Phosphatase Gene [Gene or Genome]
   757   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510755:Accession [Intellectual Product]
  1000   C1706078:Accession [Activity]

Phrase: "no."
Processing 00000000.tx.114: M31724; 

Phrase: "M31724"

Phrase: ";"
Processing 00000000.tx.115: 5' atggagatggaaaaggagttcg-3' (sense) and 5'-ctatgtgttgctgttgaacagg-3'(antisense)] and subcloned into the adenoviral shuttle vector pAdtrack (19). 

Phrase: "5' atggagatggaaaaggagttcg-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-ctatgtgttgctgttgaacagg-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "subcloned into the adenoviral shuttle vector pAdtrack"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.116: Subsequent clones were verified for integrity via bidirectional DNA sequencing and protein expression. 

Phrase: "Subsequent clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "verified for integrity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205266:integrity [Qualitative Concept]
   790   C0872403:integrity [Individual Behavior]
   790   C1711411:Verified [Functional Concept]
   790   C1947912:Integrity [Qualitative Concept]

Phrase: "via bidirectional DNA sequencing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162326:DNA sequencing [Nucleotide Sequence]
   901   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]

Phrase: "and"

Phrase: "protein expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.117: Replication-deficient adenoviruses expressing PTP-1B or green fluorescent protein (GFP), under the control of the cytomegalovirus (CMV) promoter, were generated using the pAdTrack-CMV vector and AdEasy system. 

Phrase: "Replication-deficient adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0001483:Adenoviruses [Virus]
   793 E C0001486:Adenovirus [Disease or Syndrome]
   793 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "expressing"

Phrase: "PTP-1B"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "or"

Phrase: "green fluorescent protein (GFP),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the cytomegalovirus (CMV) promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the pAdTrack-CMV vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "AdEasy system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.118: Viruses were amplified in HEK-293 cells, purified using CsCl, titered using a cytopathic effect assay, and stored in PBS containing 5% sucrose and 2 mM MgCl. 

Phrase: "Viruses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042776:Viruses [Virus]
  1000   C0521026:viruses [Functional Concept]
   966 E C0319157:virus [Virus]

Phrase: "were"

Phrase: "amplified in HEK-293 cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C2936239:HEK 293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   760   C0812263:HEK [Gene or Genome]
   760   C1704817:HEK [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CsCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]

Phrase: "titered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475208:Titer [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cytopathic effect assay,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0333467:Cytopathic effect [Pathologic Function]

Phrase: "and"

Phrase: "stored in PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1698986:Store [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "2 mM MgCl."
Processing 00000000.tx.119: BAECs were infected with PTP-1B and control (GFP) adenoviruses at multiplicity of infection of 50, and 2472 h later, cells were assayed for insulin resistance and eNOS protein expression. 

Phrase: "BAECs"

Phrase: "were"

Phrase: "infected with PTP-1B"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   882   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   783   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0439663:Infected [Functional Concept]
   753   C0450345:1B [Intellectual Product]
   753   C1149880:phosphatase [Molecular Function]

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(GFP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "adenoviruses at multiplicity of infection of 50,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   757   C0001486:Adenovirus infection [Disease or Syndrome]
       E   Adenovirus
   748   C0001483:Adenoviruses [Virus]
   714 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "2472 h later,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "assayed for insulin resistance"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "eNOS protein expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
Processing 00000000.tx.120: Chemical reagents. 

Phrase: "Chemical reagents."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0462885:Chemical reagents [Indicator, Reagent, or Diagnostic Aid]
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.121: All buffer reagents, enzymes, and glucose were acquired from Sigma. 

Phrase: "All buffer reagents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "acquired from Sigma."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0439661:Acquired [Temporal Concept]
   790   C1719918:Sigma [Intellectual Product]
   790   C3245488:acquired [Intellectual Product]
   756 E C1706701:Acquire [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.122: Statistics. 

Phrase: "Statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.123: Values are means  SE. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.124: Statistical differences were analyzed using Student's t-test or ANOVA followed by Bonferroni's multiple comparison test. 

Phrase: "Statistical differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "or"

Phrase: "ANOVA"

Phrase: "followed by Bonferroni's multiple comparison test."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0439064:Multiple [Quantitative Concept]
   753   C1707455:Comparison [Activity]
   719 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.125: Statistical significance was considered when P < 0.05.  

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "when"

Phrase: "P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.126: RESULTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Metabolic parameters. 

Phrase: "RESULTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Metabolic parameters."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]
Processing 00000000.tx.127: The baseline characteristics of young and adult LZR and OZR and lean Zucker rats fed a fructose diet are summarized in Table 1. 

Phrase: "The baseline characteristics of young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "adult LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "lean Zucker rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a fructose diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: "are"

Phrase: "summarized in Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.128: Insulin-resistant rats (young and adult OZR and fructose-fed LZR) show typical patterns of hyperinsulinemia and dsylipidemia associated with insulin resistance. 

Phrase: "Insulin-resistant rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "and"

Phrase: "adult OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0034719:Zucker rat [Mammal]
   812   C0028754:Obese [Disease or Syndrome]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "fructose-fed LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0034719:Rats, Zucker [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C2700303:Zucker [Mammal]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "typical patterns of hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "dsylipidemia"

Phrase: "associated with insulin resistance."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.129: Fructose-fed rats displayed these changes with no difference in body weight compared with LZR. 

Phrase: "Fructose-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "these changes with no difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "in body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "compared with LZR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0034719:Rats, Zucker [Mammal]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C1707455:Compared [Activity]
   760   C2700303:Zucker [Mammal]
Processing 00000000.tx.130: Young OZR were also hyperinsulinemic at a significantly lower level of obesity (44 and 68% in young and adult rats, respectively). 

Phrase: "Young OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0034719:Zucker rat [Mammal]
   812   C0028754:Obese [Disease or Syndrome]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C2700303:Zucker [Mammal]

Phrase: "were"

Phrase: "also hyperinsulinemic at a significantly lower level of obesity"

Phrase: "(44"

Phrase: "and"

Phrase: "68% in young"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332239:Young [Temporal Concept]
   790   C0450387:68 [Intellectual Product]

Phrase: "and"

Phrase: "adult rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.131: Finally, fasting levels of blood glucose were comparable in all rats, documenting insulin resistance, but not frank hyperglycemia, in the models chosen. 

Phrase: "Finally,"

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "levels of blood glucose"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   881   C0428554:blood glucose levels [Laboratory or Test Result]
   819   C0428548:glucose levels [Laboratory or Test Result]
   802 E C0337438:glucose level [Laboratory Procedure]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "comparable in all rats,"

Phrase: "documenting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1301725:documenting [Health Care Activity]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "frank"

Phrase: "hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "in the models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "chosen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]
Processing 00000000.tx.132: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.133: Baseline characteristics of young and adult LZR and OZR  Endothelium-dependent relaxation and plasma NOx. 

Phrase: "Baseline characteristics of young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "adult LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "OZR  Endothelium-dependent relaxation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0014257:Endothelium [Tissue]
   799   C0035028:Relaxation [Activity]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "plasma NOx."
Processing 00000000.tx.134: Assessment of endothelium-dependent dilation is shown in Fig. 

Phrase: "Assessment of endothelium-dependent dilation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.135: 1A. 

Phrase: "1A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]
Processing 00000000.tx.136: As reported previously (14), acetylcholine caused dose-dependent increases in vascular diameter in gracilis from LZR, reaching a maximal effect of 84  4%. 

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "acetylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "dose-dependent increases in vascular diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "in gracilis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0224439:Gracilis [Body Part, Organ, or Organ Component]
  1000   C1305058:Gracilis [Body Part, Organ, or Organ Component]

Phrase: "from LZR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "a maximal effect of 84  4%."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205289:Maximal [Qualitative Concept]
   753   C0806909:Maximal [Quantitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.137: In contrast, acetylcholine-induced dilation was blunted in gracilis arteries from OZR, reaching only 43  7% response (P < 0.05, n = 6). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "acetylcholine-induced dilation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0012359:Dilation [Pathologic Function]
   827   C0393293:Dilation [Therapeutic or Preventive Procedure]
   827   C0700124:Dilation [Functional Concept]

Phrase: "was"

Phrase: "blunted in gracilis arteries"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003842:Arteries [Body Part, Organ, or Organ Component]
   770   C0224439:Gracilis [Body Part, Organ, or Organ Component]
   770   C0226004:arteries [Body System]
   770   C1305058:Gracilis [Body Part, Organ, or Organ Component]
   770   C1997138:Blunted [Qualitative Concept]

Phrase: "from OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "only 43  7% response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "(P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.138: This finding confirms the existence of impaired NO-mediated vasodilation in OZR. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the existence of impaired NO-mediated vasodilation"

Phrase: "in OZR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.139: As a corollary, we determined plasma NOx as an index of in vivo NO production. 

Phrase: "As a corollary,"

Phrase: "we"

Phrase: "determined"

Phrase: "plasma NOx as an index of in vivo NO production."
Processing 00000000.tx.140: Plasma levels of NO2 were significantly less in OZR than in LZR (Fig 1B). 

Phrase: "Plasma levels of NO2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly less in OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0034719:Zucker rat [Mammal]
   753   C0028754:Obese [Disease or Syndrome]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C2700303:Zucker [Mammal]

Phrase: "than"

Phrase: "in LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(Fig 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.141: NO3 and total NOx species were reduced in OZR vs. 

Phrase: "NO3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919442:NO3 [Gene or Genome]
  1000   C1705347:NO3 [Gene or Genome]

Phrase: "and"

Phrase: "total NOx species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "were"

Phrase: "reduced in OZR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034719:Zucker rat [Mammal]
   760   C0028754:Obese [Disease or Syndrome]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0392756:Reduced [Qualitative Concept]
   760   C2700303:Zucker [Mammal]

Phrase: "vs."
Processing 00000000.tx.142: LZR but did not achieve statistical significance. 

Phrase: "LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieve"

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.143: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.145: Impaired endothelium-dependent vasodilation and reduced plasma NO2 in obese Zucker rats (OZR). 

Phrase: "Impaired endothelium-dependent vasodilation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0042401:Vasodilation [Physiologic Function]
   812   C0595862:VASODILATION [Pathologic Function]
   812   C3537065:Vasodilation [Physiologic Function]

Phrase: "and"

Phrase: "reduced plasma NO2 in obese Zucker rats"

Phrase: "(OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: ")."
Processing 00000000.tx.146: A: pressurized gracilis arteries (60 mmHg) from lean Zucker rats (LZR) and OZR were preconstricted with 106 M phenylephrine, and endothelium-dependent vasodilation to 1073 x 105 M ACh was obtained. 

Phrase: "A"

Phrase: ":"

Phrase: "pressurized gracilis arteries"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003842:Arteries [Body Part, Organ, or Organ Component]
   827   C0226004:arteries [Body System]
   743 E C0221464:Arterial [Spatial Concept]

Phrase: "(60 mmHg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439475:mmHg [Quantitative Concept]

Phrase: ")"

Phrase: "from lean Zucker rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: ")"

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "were"

Phrase: "preconstricted with 106 M phenylephrine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0626189:M 106 [Organic Chemical,Pharmacologic Substance]
   760   C0031469:Phenylephrine [Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "endothelium-dependent vasodilation to 1073 x 105 M ACh"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0042401:Vasodilation [Physiologic Function]
   742   C0595862:VASODILATION [Pathologic Function]
   742   C3537065:Vasodilation [Physiologic Function]

Phrase: "was"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.147: Data are expressed as percent increase in preconstricted diameter (n = 5). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as percent increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439165:Percent [Quantitative Concept]
   770   C0442805:Increase [Functional Concept]

Phrase: "in preconstricted diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1301886:Diameter [Quantitative Concept]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.148: *P < 0.05. 

Phrase: "*P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.149: B: NO2, NO3, and NO2 + NO3 (NOx) in plasma from LZR and OZR (n = 12). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "NO2,"

Phrase: "NO3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919442:NO3 [Gene or Genome]
  1000   C1705347:NO3 [Gene or Genome]

Phrase: "and"

Phrase: "NO2 + NO3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919442:NO3 [Gene or Genome]
   861   C1705347:NO3 [Gene or Genome]

Phrase: "(NOx"

Phrase: ")"

Phrase: "in plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "from LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(n = 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.150: ns, Not significant.  

Phrase: "ns,"

Phrase: "Not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.151: eNOS protein expression. 

Phrase: "eNOS protein expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
Processing 00000000.tx.152: Expression of eNOS protein is documented in Fig. 

Phrase: "Expression of eNOS protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "documented in Fig."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0349966:Fig [Food]
   790   C1301725:Documented [Health Care Activity]
   790   C1337208:FIG [Food]
   790   C1609436:documented [Idea or Concept]
   756 E C1301746:document [Intellectual Product]
   756 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.153: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.154: Western blot analysis of eNOS protein from the hearts of young (68 wk old, Fig. 2A) and adult (1025 wk old, Fig. 2B) Zucker rats shows no difference in the levels of expression between obese and lean rats. 

Phrase: "Western blot analysis of eNOS protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]

Phrase: "from the hearts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018787:Hearts [Body Part, Organ, or Organ Component]
   966 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "of young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(68 wk old,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "Fig. 2A"

Phrase: ")"

Phrase: "and"

Phrase: "adult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001675:Adult [Age Group]
  1000   C1706450:Adult [Human]

Phrase: "(1025 wk old,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "Zucker rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034719:Rats, Zucker [Mammal]
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C2700303:Zucker [Mammal]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no difference in the levels of expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028754:Obese [Disease or Syndrome]

Phrase: "and"

Phrase: "lean rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.155: Consistent with these findings, no significant difference was observed in two other vascular tissues: aorta (Fig. 2C) and skeletal muscle (Fig. 2D). 

Phrase: "Consistent with these findings,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed in two"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205448:Two [Quantitative Concept]
   790   C1441672:Observed [Functional Concept]

Phrase: "other vascular tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   955   C1511228:Blood Vessel Tissue [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: ":"

Phrase: "aorta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003483:Aorta [Body Part, Organ, or Organ Component]
  1000   C1278934:Aorta [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "and"

Phrase: "skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.156: We next determined the level of eNOS expression in two other models of insulin resistance: eNOS was affinity purified from the hearts of fructose-fed rats and C57BL/6J (control) and obese (ob/ob) mice. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "determined"

Phrase: "the level of eNOS expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C3244092:expression level [Idea or Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other models of insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from the hearts of fructose-fed rats"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0016745:Fructose [Carbohydrate,Pharmacologic Substance]
   744   C0018787:Hearts [Body Part, Organ, or Organ Component]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0342895:FED [Disease or Syndrome]
   744   C1998793:Purified [Functional Concept]
   734   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   711 E C0204695:Feed [Health Care Activity]
   711 E C1281570:Heart [Body Part, Organ, or Organ Component]
   711 E C2987508:Feed [Activity]

Phrase: "and"

Phrase: "C57BL/6J"

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028754:Obese [Disease or Syndrome]

Phrase: "(ob/ob) mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.157: The relative expression of eNOS was not significantly different between ob/ob mice (Fig. 3A) and control (LZR) and fructose-fed rats (Fig. 3B). 

Phrase: "The relative expression of eNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not significantly different between ob/ob mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: ")"

Phrase: "and"

Phrase: "fructose-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.158: These models, in which insulin resistance is independent of leptin resistance (in both cases) and obesity (in the former case), were without differences in the level of eNOS protein expression. 

Phrase: "These models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "in which insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is independent of leptin resistance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0332291:Independent of [Functional Concept]
   760   C0085862:Independent [Idea or Concept]
   760   C0237834:Resistance [Mental Process]
   760   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
   760   C1299583:Independent [Finding]
   760   C1416825:LEPTIN [Gene or Genome]
   760   C1514892:Resistance [Physiologic Function]

Phrase: "("

Phrase: "in both cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "("

Phrase: "in the former case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "were without differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of eNOS protein expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
Processing 00000000.tx.159: View larger version (31K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.160: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.161: Expression of endothelial nitric oxide (NO) synthase (eNOS) is unchanged in vasculature of OZR. 

Phrase: "Expression of endothelial nitric oxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(NO) synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")"

Phrase: "is"

Phrase: "unchanged in vasculature of OZR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0442739:Unchanged [Finding]
   748   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.162: eNOS was affinity purified from heart and skeletal muscle of LZR and OZR and, together with aortic cell lysates, was immunblotted for total eNOS. 

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from heart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018787:Heart [Body Part, Organ, or Organ Component]
   790   C1281570:Heart [Body Part, Organ, or Organ Component]
   790   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "skeletal muscle of LZR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   790   C0242692:Muscle, Skeletal [Tissue]
   790   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   753   C0026845:Muscle [Tissue]
   753   C0037253:skeletal [Body System]
   753   C0521324:Skeletal [Spatial Concept]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: ","

Phrase: "together with aortic cell lysates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "immunblotted for total eNOS."
Processing 00000000.tx.163: Densitometric values obtained for individual eNOS bands are presented along with representative immunoblots. 

Phrase: "Densitometric values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "obtained for individual eNOS bands"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   833   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   800   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0014257:Endothelial [Tissue]
   744   C0027361:Individual [Population Group]
   744   C0030015:oxide [Inorganic Chemical]
   744   C0175723:Bands [Medical Device]
   744   C0237401:Individual [Human]
   744   C1301820:Obtained [Functional Concept]
   744   C2986642:oxide [Chemical Viewed Functionally]
   711 E C0439645:Band [Spatial Concept]
   711 E C1521913:band [Cell Component]
   711 E C1706701:Obtain [Activity]

Phrase: "are"

Phrase: "presented along with representative immunoblots."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0449450:Presented [Idea or Concept]
   760   C1882932:Representative [Activity]
   726   C0020985:Immunoblot [Laboratory Procedure]
   726 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.164: A and B: eNOS expression levels in hearts of young (A; 68 wk old, n = 4) and adult (B; 1025 wk old, n = 4) OZR and LZR. 

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "eNOS expression levels in hearts of young"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0441889:Levels [Qualitative Concept]
   726   C3244092:expression level [Idea or Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(A"

Phrase: "; 68 wk old,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "adult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001675:Adult [Age Group]
  1000   C1706450:Adult [Human]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "; 1025 wk old,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "LZR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.165: C and D: aortic (C) and skeletal muscle (D) eNOS in LZR and OZR (n = 4).  

Phrase: "C"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "aortic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003483:Aortic [Body Part, Organ, or Organ Component]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "("

Phrase: "D)"

Phrase: "eNOS in LZR"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   839   C1565682:endothelial nitric oxide synthase, rat [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   800   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0014257:Endothelial [Tissue]
   744   C0030015:oxide [Inorganic Chemical]
   744   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.166: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.167: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.168: eNOS expression is not diminished in other in vivo models of insulin resistance. 

Phrase: "eNOS expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "diminished in other in vivo models of insulin resistance."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   773   C1515657:In Vivo Model [Research Activity]
   764   C0021655:Insulin Resistance [Pathologic Function]
   764   C2700570:INSULIN RESISTANCE [Gene or Genome]
   762   C1515655:In Vivo [Spatial Concept]
           vivo
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0205216:Diminished [Quantitative Concept]
   742   C0237834:Resistance [Mental Process]
   742   C1514892:Resistance [Physiologic Function]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C3161035:Models [Intellectual Product]
Processing 00000000.tx.169: eNOS was affinity purified from hearts of ob/ob mice (A; n = 4) and fructose-fed rats (B; n = 4) and immunoblotted for total eNOS.  

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from hearts of ob/ob mice"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0018787:Hearts [Body Part, Organ, or Organ Component]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C1998793:Purified [Functional Concept]
   741   C1512359:Mouse Heart [Tissue]
   714 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(A"

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "fructose-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "immunoblotted for total eNOS."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   853   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   814   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0014257:Endothelial [Tissue]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C2986642:oxide [Chemical Viewed Functionally]
   714   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.170: eNOS mRNA expression. 

Phrase: "eNOS mRNA expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1515670:mRNA Expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
Processing 00000000.tx.171: Expression of eNOS mRNA is documented in Fig. 

Phrase: "Expression of eNOS mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1515670:mRNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "documented in Fig."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0349966:Fig [Food]
   790   C1301725:Documented [Health Care Activity]
   790   C1337208:FIG [Food]
   790   C1609436:documented [Idea or Concept]
   756 E C1301746:document [Intellectual Product]
   756 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.172: 4. 

Phrase: "4."
Processing 00000000.tx.173: Total RNA was extracted from the hearts of LZR and OZR, and the integrity of ribosomal 28S/18S is shown in Fig. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from the hearts of LZR"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0034719:Rats, Zucker [Mammal]
   744   C0018787:Hearts [Body Part, Organ, or Organ Component]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C2700303:Zucker [Mammal]
   744   C3541890:EXTRACTED [Finding]
   734   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   711 E C1281570:Heart [Body Part, Organ, or Organ Component]
   711 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "the integrity of ribosomal 28S/18S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205266:integrity [Qualitative Concept]
   753   C0872403:integrity [Individual Behavior]
   753   C1947912:Integrity [Qualitative Concept]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.174: 4A. 

Phrase: "4A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]
Processing 00000000.tx.175: Optimal PCR primers were designed for rat eNOS, and the sensitivity and selectivity of these probes are shown in Fig. 

Phrase: "Optimal PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed for rat eNOS,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   897   C1565682:endothelial nitric oxide synthase, rat [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   853   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   814   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0014257:Endothelial [Tissue]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C2986642:oxide [Chemical Viewed Functionally]
   714   C1707689:Design [Activity]
   714   C2983265:DESIGN [Intellectual Product]

Phrase: "and"

Phrase: "the sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "selectivity of these probes"

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.176: 4B, with the amplification of as little as 1 pg of eNOS cDNA. 

Phrase: "4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "with the amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "of"

Phrase: "as"

Phrase: "little as 1 pg of eNOS cDNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   739   C0700321:Little [Quantitative Concept]
   739   C2700395:Little [Quantitative Concept]
Processing 00000000.tx.177: Quantitative assessment of eNOS mRNA levels, as determined by real-time PCR, reveals no significant difference between LZR and OZR (Fig. 4C). 

Phrase: "Quantitative assessment of eNOS mRNA levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1261322:Assessment [Health Care Activity]
   742   C1516048:Assessment [Activity]

Phrase: "as"

Phrase: "determined by real-time PCR,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   862   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   806   C1550177:Real Time [Idea or Concept]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040223:Time [Temporal Concept]
   760   C0237400:Real [Qualitative Concept]
   760   C0677874:pCR [Finding]
   760   C3272377:REAL [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "no significant difference between LZR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: These findings are consistent, whether normalized to the abundant and ubiquitous HSP-90 or to the endothelial cell-specific Tie2 gene. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332290:Consistent [Idea or Concept]
   928 E C0332529:Consistencies [Qualitative Concept]
   928 E C1547017:Consistency [Quantitative Concept]

Phrase: "whether"

Phrase: "normalized to the abundant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1882115:Normalized [Research Activity]
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "ubiquitous HSP-90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0282498:Heat Shock [Physiologic Function]
   804   C0018837:Heat [Natural Phenomenon or Process]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0036974:Shock [Pathologic Function]
   804   C0439083:>90 [Quantitative Concept]
   804   C0439087:<90 [Quantitative Concept]

Phrase: "or to the endothelial cell-specific Tie2 gene."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0225336:Endothelial cell [Cell]
   767   C1861886:CELL Gene [Gene or Genome]
   744   C0007634:Cell [Cell]
   744   C0014257:Endothelial [Tissue]
   744   C0017337:Gene [Gene or Genome]
   744   C0205369:Specific [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1336602:TIE2 [Gene or Genome]
   744   C1552740:specific [Intellectual Product]
   744   C1704653:Cell [Medical Device]
   744   C1705001:TIE2 [Gene or Genome]
   744   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.179: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.180: 4. 

Phrase: "4."
Processing 00000000.tx.181: eNOS mRNA levels are not different between LZR and OZR. 

Phrase: "eNOS mRNA levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "are"

Phrase: "not different between LZR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "OZR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.182: A: integrity of ribosomal RNA from total RNA extracted from hearts of LZR and OZR. 

Phrase: "A"

Phrase: ":"

Phrase: "integrity of ribosomal RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205266:integrity [Qualitative Concept]
   770   C0872403:integrity [Individual Behavior]
   770   C1947912:Integrity [Qualitative Concept]

Phrase: "from total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted from hearts of LZR"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0034719:Rats, Zucker [Mammal]
   748   C0018787:Hearts [Body Part, Organ, or Organ Component]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C2700303:Zucker [Mammal]
   748   C3541890:EXTRACTED [Finding]
   741   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   714 E C1281570:Heart [Body Part, Organ, or Organ Component]
   714 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "OZR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.183: B: primers designed to amplify rat eNOS were specific and highly sensitive. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "rat eNOS"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1565682:endothelial nitric oxide synthase, rat [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   884   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0014257:Endothelial [Tissue]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "were"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "highly sensitive."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439822:Highly sensitive [Qualitative Concept]
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.184: C: quantitative comparison of eNOS mRNA levels in hearts of LZR and OZR. 

Phrase: "C"

Phrase: ":"

Phrase: "quantitative comparison of eNOS mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "in hearts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018787:Hearts [Body Part, Organ, or Organ Component]
   966 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "of LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "OZR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.185: Level of eNOS mRNA was not significantly different between groups whether normalized to heat shock protein 90 (HSP-90, n = 8) or endothelial cell-specific Tie2 (data not shown). 

Phrase: "Level of eNOS mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "not significantly different between"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "whether"

Phrase: "normalized to heat shock protein 90 (HSP-90, n = 8)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0282498:Heat Shock [Physiologic Function]
   753   C0018837:Heat [Natural Phenomenon or Process]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036974:Shock [Pathologic Function]
   753   C0439083:>90 [Quantitative Concept]
   753   C0439087:<90 [Quantitative Concept]
   753   C1882115:Normalized [Research Activity]

Phrase: "or"

Phrase: "endothelial cell-specific Tie2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1336602:TIE2 [Gene or Genome]
   812   C1705001:TIE2 [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.186: There was no significant difference in expression of Tie2 between OZR and LZR. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in expression of Tie2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "LZR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.187: Ct, cycle threshold.  

Phrase: "Ct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "cycle threshold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.188: Expression of other NOS isoforms. 

Phrase: "Expression of other NOS isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.189: In addition to eNOS, NO is also produced by iNOS and nNOS. 

Phrase: "In addition to eNOS,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "also"

Phrase: "produced by iNOS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205263:Inducible [Functional Concept]
   770   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1518425:{NOS} [Qualitative Concept]

Phrase: "and"

Phrase: "nNOS."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]
Processing 00000000.tx.190: The relative levels of expression of iNOS and nNOS were not significantly different in cardiac tissue between LZR and OZR (Fig. 5, A and B). 

Phrase: "The relative levels of expression of iNOS"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C3244092:expression level [Idea or Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "were"

Phrase: "not significantly different in cardiac tissue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "between LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.191: Furthermore, expression of HSP-90, which we employed as a housekeeping gene, was not different between LZR and OZR (Fig. 5C). 

Phrase: "Furthermore,"

Phrase: "expression of HSP-90,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "we"

Phrase: "employed as a housekeeping gene,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1334046:House-keeping Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0020053:Housekeeping [Occupational Activity]
   760   C0557351:Employed [Finding]
   726 E C0457083:Employ [Functional Concept]

Phrase: "was"

Phrase: "not different between LZR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.192: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.193: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.194: Cardiac expression of neuronal and inducible NOS isoforms (nNOS and iNOS, respectively) is unchanged in OZR. 

Phrase: "Cardiac expression of neuronal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "inducible NOS isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "iNOS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "is"

Phrase: "unchanged in OZR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.195: NOS was affinity purified from hearts of lean LZR and OZR and immunoblotted with antibodies that recognize rat iNOS (A; n = 4), nNOS (B; n = 4), or the abundantly expressed HSP-90 (C; n = 4)  Insulin resistance in endothelial cells in vitro. 

Phrase: "NOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518425:{NOS} [Qualitative Concept]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from hearts of lean LZR"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0034719:Rats, Zucker [Mammal]
   744   C0018787:Hearts [Body Part, Organ, or Organ Component]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C1998793:Purified [Functional Concept]
   744   C2700303:Zucker [Mammal]
   734   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   711 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "immunoblotted with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756   C0020985:Immunoblot [Laboratory Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognize"

Phrase: "rat iNOS (A"

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "nNOS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0521390:Neuronal [Immunologic Factor]
   861   C1518425:{NOS} [Qualitative Concept]
   789 E C0027882:Neuron [Cell]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the abundantly expressed HSP-90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0282498:Heat Shock [Physiologic Function]
   799   C0018837:Heat [Natural Phenomenon or Process]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0036974:Shock [Pathologic Function]
   799   C0439083:>90 [Quantitative Concept]
   799   C0439087:<90 [Quantitative Concept]

Phrase: "(C"

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "Insulin resistance in endothelial cells"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   781   C0030281:Insulin Cell [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.196: In a fourth model of insulin resistance, we used adenovirus-mediated gene delivery to endothelial cells in culture to overexpress PTP-1B. 

Phrase: "In a fourth model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "adenovirus-mediated gene delivery to endothelial cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0872177:gene delivery [Genetic Function]
   778   C1524066:Gene Delivery [Conceptual Entity]
   748   C0011209:Delivery [Therapeutic or Preventive Procedure]
   748   C0559563:delivery [Finding]
   748   C1705822:Delivery [Activity]

Phrase: "in culture to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "PTP-1B."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.197: This model excludes the possible influence of hemodynamic forces, hyperglycemia, and dyslipidemia on eNOS gene expression. 

Phrase: "This model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "excludes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possible influence of hemodynamic forces,"

Phrase: "hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "dyslipidemia on eNOS gene expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0242339:Dyslipidaemia [Disease or Syndrome]
Processing 00000000.tx.198: PTP-1B specifically dephosphorylates and, thus, reduces the activity of the insulin receptor and is believed to be upregulated in states of insulin resistance (4). 

Phrase: "PTP-1B specifically"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   937   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   853   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0450345:1B [Intellectual Product]
   804   C1149880:phosphatase [Molecular Function]

Phrase: "dephosphorylates"

Phrase: "and"

Phrase: ","

Phrase: "thus,"

Phrase: "reduces"

Phrase: "the activity of the insulin receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   820   C1150623:insulin receptor activity [Molecular Function]
   783   C1145751:insulin activity [Molecular Function]
   783   C1152633:receptor activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "upregulated in states of insulin resistance"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1301808:states [Geographic Area]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C1442792:State [Functional Concept]
   719 E C3148680:State [Geographic Area]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.199: Confluent BAECs were transduced with adenoviruses encoding GFP (control) or PTP-1B. 

Phrase: "Confluent BAECs"

Phrase: "were"

Phrase: "transduced with adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0001483:Adenoviruses [Virus]
   756 E C0001486:Adenovirus [Disease or Syndrome]
   756 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "GFP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "PTP-1B."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.200: Cells were allowed to recover for 72 h and then immunoblotted for expression of total eNOS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover for 72 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0521108:recover [Qualitative Concept]
   770   C0564385:/h [Quantitative Concept]
   770   C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoblotted for expression of total eNOS."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   790   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0014257:Endothelial [Tissue]
   742   C0030015:oxide [Inorganic Chemical]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C2986642:oxide [Chemical Viewed Functionally]
   708   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.201: The insulin receptor was dephosphorylated in endothelial cells transduced with the PTP-1B adenovirus vs. control (GFP) cells (Fig. 6A). 

Phrase: "The insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "dephosphorylated in endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0225336:Endothelial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0014257:Endothelial [Tissue]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "transduced with the PTP-1B adenovirus"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   767   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0001483:Adenovirus, NOS [Virus]
   744   C0001486:Adenovirus [Disease or Syndrome]
   744   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0450345:1B [Intellectual Product]
   744   C1149880:phosphatase [Molecular Function]
   744   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(GFP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.202: In addition, in response to insulin, the activation of Akt, as indicated by phosphorylation of S473, was abolished in cells overexpressing PTP-1B (Fig. 6B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the activation of Akt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "as"

Phrase: "indicated by phosphorylation of S473,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1444656:Indicated [Finding]

Phrase: "was"

Phrase: "abolished in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PTP-1B"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.203: Having demonstrated an inability of these cells to respond to insulin, we next looked at the expression of eNOS. 

Phrase: "Having"

Phrase: "demonstrated"

Phrase: "an inability of these cells to"

Phrase: "respond to insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "looked at the expression of eNOS."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   790   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C0014257:Endothelial [Tissue]
   742   C0030015:oxide [Inorganic Chemical]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C2986642:oxide [Chemical Viewed Functionally]
   708   C0233426:look [Organism Attribute]
Processing 00000000.tx.204: In endothelial cells treated with insulin for 72 h, eNOS expression levels were not significantly different between GFP- and PTP-1B-overexpressing cells (Fig. 6A). 

Phrase: "In endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 72 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "eNOS expression levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   799   C0441889:Levels [Qualitative Concept]
   793   C3244092:expression level [Idea or Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "were"

Phrase: "not significantly different between GFP-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "PTP-1B-overexpressing cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   734   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.205: To determine the functional relevance of insulin resistance in endothelial cells, we measured the release of NO via its stable end product in aqueous media, NO2. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the functional relevance of insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevance [Qualitative Concept]

Phrase: "in endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the release of NO"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "via its stable end product"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0444930:End [Spatial Concept]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]
   827   C2746065:End [Temporal Concept]
   771 E C0205088:Terminal [Temporal Concept]
   771 E C1705314:Terminal [Manufactured Object]
   771 E C1705315:Terminal [Spatial Concept]

Phrase: "in aqueous media,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "NO2."
Processing 00000000.tx.206: In endothelial cells transduced with PTP-1B, the ability of insulin to acutely stimulate NO release was abolished relative to control (GFP-transduced) cells (Fig. 6C). 

Phrase: "In endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transduced with PTP-1B,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   882   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   783   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0450345:1B [Intellectual Product]
   753   C1149880:phosphatase [Molecular Function]

Phrase: "the ability of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "to acutely"

Phrase: "stimulate"

Phrase: "NO release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "abolished"

Phrase: "relative to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(GFP-transduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.207: Overall capacity to produce NO was unaffected, inasmuch as the ability of ionomycin to directly stimulate NO was equivalent in both populations of cells (Fig. 6C, right). 

Phrase: "Overall capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "produce"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "unaffected,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "inasmuch as"

Phrase: "the ability of ionomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "stimulate"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "equivalent in both populations of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205163:Equivalent [Qualitative Concept]
   753   C0439185:equivalent [Quantitative Concept]

Phrase: "(Fig. 6C,"

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.208: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.209: 6. 

Phrase: "6."
Processing 00000000.tx.210: No change in eNOS expression in an in vitro model of insulin resistance. 

Phrase: "No change in eNOS expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442739:No change [Finding]
   770   C1548568:No change [Intellectual Product]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "in an in vitro model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1515654:In Vitro Model [Research Activity]
   827   C3161035:Model [Intellectual Product]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "of insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.211: Endothelial cells were transduced with adenoviruses (multiplicity of infection = 50) expressing green fluorescent protein (GFP, viral control) or protein tyrosine phosphatase (PTP) 1B, which specifically dephosphorylates the insulin receptor (IR). 

Phrase: "Endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transduced with adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0001483:Adenoviruses [Virus]
   756 E C0001486:Adenovirus [Disease or Syndrome]
   756 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(multiplicity of infection"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0009450:Infection, NOS [Disease or Syndrome]
   827   C0449822:Multiplicity [Quantitative Concept]
   755 E C0439064:Multiple [Quantitative Concept]
   755 E C0439663:Infected [Functional Concept]
   716 E C0030657:infectivity [Qualitative Concept]

Phrase: "= 50"

Phrase: ")"

Phrase: "expressing"

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "(GFP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "viral control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "protein tyrosine phosphatase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   913   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1149880:phosphatase [Molecular Function]

Phrase: "(PTP) 1B,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "which specifically"

Phrase: "dephosphorylates"

Phrase: "the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IR"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.212: A: PTP-1B overexpression dephosphorylates the insulin receptor but does not reduce eNOS protein expression. 

Phrase: "A"

Phrase: ":"

Phrase: "PTP-1B overexpression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   771   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "dephosphorylates"

Phrase: "the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "eNOS protein expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
Processing 00000000.tx.213: B: insulin (100 nM) and vascular endothelial growth factor (VEGF, 50 ng/ml, 5 min) stimulate phosphorylation of the downstream effector Akt in GFP-treated endothelial cells, but insulin is unable to activate Akt in PTP-1B-overexpressing cells. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "vascular endothelial growth factor"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "(VEGF,"

Phrase: "50 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "5 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "stimulate"

Phrase: "phosphorylation of the downstream effector Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "in GFP-treated endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0225336:Endothelial Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C0014257:Endothelial [Tissue]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Akt in PTP-1B-overexpressing cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.214: Con, control. 

Phrase: "Con,"

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.215: C: bovine aortic endothelial cells transduced (multiplicity of infection = 50) with adenovirus (Ad) encoding GFP or PTP-1B were stimulated with insulin (100 nM) or ionomycin (1 M). 

Phrase: "C"

Phrase: ":"

Phrase: "bovine aortic endothelial cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0225336:Endothelial Cells [Cell]
   812   C0003483:Aortic [Body Part, Organ, or Organ Component]
   812   C0007452:Bovine [Mammal]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C1140701:bovine [Mammal]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transduced"

Phrase: "(multiplicity of infection"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0009450:Infection, NOS [Disease or Syndrome]
   827   C0449822:Multiplicity [Quantitative Concept]
   755 E C0439064:Multiple [Quantitative Concept]
   755 E C0439663:Infected [Functional Concept]
   716 E C0030657:infectivity [Qualitative Concept]

Phrase: "= 50"

Phrase: ")"

Phrase: "with adenovirus (Ad)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001483:Adenovirus, NOS [Virus]
  1000   C0001486:Adenovirus [Disease or Syndrome]
  1000   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "GFP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "or"

Phrase: "PTP-1B"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "were"

Phrase: "stimulated with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "or"

Phrase: "ionomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022020:Ionomycin [Lipid,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)."
Processing 00000000.tx.216: Ability of insulin to liberate NO is abolished in PTP-1B-overexpressing cells, whereas ionomycin generates equivalent levels of NO (n = 6). 

Phrase: "Ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "liberate"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "abolished in PTP-1B-overexpressing cells,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   833   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   767   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0007634:Cells [Cell]
   744   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0450345:1B [Intellectual Product]
   744   C1149880:phosphatase [Molecular Function]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711   C1514559:overexpress [Genetic Function]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "ionomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022020:Ionomycin [Lipid,Pharmacologic Substance]

Phrase: "generates"

Phrase: "equivalent levels of NO"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0439185:equivalent [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.217: *P < 0.05.  

Phrase: "*P < 0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.218: Posttranslational modification of eNOS. 

Phrase: "Posttranslational modification of eNOS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0033666:Post-Translational Modification [Molecular Function]
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.219: The activity of eNOS is highly regulated by posttranslational modifications, including phosphorylation and protein-protein interactions. 

Phrase: "The activity of eNOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1151383:nitric-oxide synthase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "regulated by posttranslational modifications,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0033666:Post-Translational Modifications [Molecular Function]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "protein-protein interactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.220: The phosphorylation of eNOS at human T495 [T495(hum)] is reported to inhibit enzyme activity and increase O2 formation. 

Phrase: "The phosphorylation of eNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "at human T495"

Phrase: "[T495"

Phrase: "(hum"

Phrase: ")"

Phrase: "]"

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "increase O2 formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.221: In contrast, phosphorylation of S1177(hum) and S633(hum) is associated with increased enzyme activity. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "phosphorylation of S1177"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "(hum"

Phrase: ")"

Phrase: "and"

Phrase: "S633"

Phrase: "(hum"

Phrase: ")"

Phrase: "is"

Phrase: "associated with increased enzyme activity."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0243102:enzyme activity [Molecular Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0474395:increased activity [Finding]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205177:Activity [Functional Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0442805:Increased [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.222: We next examined whether the level of eNOS phosphorylation at T494, S632, and S1176 was different in OZR and LZR (Fig. 7). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the level of eNOS phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "at T494,"

Phrase: "S632,"

Phrase: "and"

Phrase: "S1176"

Phrase: "was"

Phrase: "different in OZR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.223: The level of eNOS phosphorylation at S1176 normalized to total eNOS is significantly increased in hearts of OZR vs. 

Phrase: "The level of eNOS phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "at S1176"

Phrase: "normalized to total eNOS"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   853   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   814   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0014257:Endothelial [Tissue]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1882115:Normalized [Research Activity]
   748   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "significantly"

Phrase: "increased in hearts of OZR"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0034719:Zucker rat [Mammal]
   757   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   748   C0018787:Hearts [Body Part, Organ, or Organ Component]
   748   C0028754:Obese [Disease or Syndrome]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C2700303:Zucker [Mammal]
   714 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "vs."
Processing 00000000.tx.224: LZR (Fig. 7A). 

Phrase: "LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.225: In contrast, in the other two models of insulin resistance, the fructose-fed rat and the ob/ob mouse, there was no significant difference in S1176 phosphorylation (Fig. 8). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in the"

Phrase: "other two models of insulin resistance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Models [Intellectual Product]

Phrase: "the fructose-fed rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "the ob/ob mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in S1176 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.226: The degree of phosphorylation at the other regulatory sites, T494 and S632, was not significantly different between groups (Fig. 7, B and C). 

Phrase: "The degree of phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "at the"

Phrase: "other regulatory sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "T494"

Phrase: "and"

Phrase: "S632,"

Phrase: "was"

Phrase: "not significantly different between groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.227: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.228: 7. 

Phrase: "7."
Processing 00000000.tx.229: Posttranslational phosphorylation of eNOS is not reduced in OZR. 

Phrase: "Posttranslational phosphorylation of eNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduced in OZR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034719:Zucker rat [Mammal]
   760   C0028754:Obese [Disease or Syndrome]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0392756:Reduced [Qualitative Concept]
   760   C2700303:Zucker [Mammal]
Processing 00000000.tx.230: eNOS was affinity purified from hearts of LZR and OZR and immunoblotted with phosphorylation state-specific antibodies to S1176 (equivalent to human S1177), S632 (human S633), and T494 (human T495). 

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from hearts of LZR"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0034719:Rats, Zucker [Mammal]
   748   C0018787:Hearts [Body Part, Organ, or Organ Component]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C1998793:Purified [Functional Concept]
   748   C2700303:Zucker [Mammal]
   741   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   714 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "immunoblotted with phosphorylation state-specific antibodies"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C1257988:Phosphorylation State-Specific Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   773   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0205369:Specific [Qualitative Concept]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C1552740:specific [Intellectual Product]
   753   C3148680:State [Geographic Area]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to S1176"

Phrase: "(equivalent to human S1177"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205163:Equivalent [Qualitative Concept]
   770   C0439185:equivalent [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "S632"

Phrase: "(human S633"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "T494"

Phrase: "(human T495"

Phrase: ")."
Processing 00000000.tx.231: A: level of S1176 phosphorylation is significantly higher in OZR than in LZR (n = 7). 

Phrase: "A"

Phrase: ":"

Phrase: "level of S1176 phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "significantly higher in OZR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in LZR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "(n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.232: Degree of T494 (B; n = 4) and S632 (C; n = 4) phosphorylation was not different between groups.  

Phrase: "Degree of T494"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0441889:Degree [Qualitative Concept]
   790   C0449286:Degree [Quantitative Concept]
   790   C0542560:Degree [Intellectual Product]
   790   C1561545:degree [Quantitative Concept]
   790   C2348088:Degree [Quantitative Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "S632"

Phrase: "(C"

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "not different between groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.233: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.234: 8. 

Phrase: "8."
Processing 00000000.tx.235: Phosphorylation of S1176 is unchanged in ob/ob mice and fructose-fed rats. 

Phrase: "Phosphorylation of S1176"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "unchanged in ob/ob mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]

Phrase: "and"

Phrase: "fructose-fed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.236: eNOS was affinity purified from hearts of ob/ob mice (A; n = 4) and fructose-fed rats (B; n = 4) and immunoblotted with antibodies to phosphorylated S1176 (human S1177).  

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified from hearts of ob/ob mice"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0018787:Hearts [Body Part, Organ, or Organ Component]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C1998793:Purified [Functional Concept]
   741   C1512359:Mouse Heart [Tissue]
   714 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(A"

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "fructose-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "; n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "immunoblotted with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756   C0020985:Immunoblot [Laboratory Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to phosphorylated S1176"

Phrase: "(human S1177"

Phrase: ")."
Processing 00000000.tx.237: The protein-protein interaction of HSP-90 with eNOS acutely regulates eNOS activity and can facilitate phosphorylation of S1177(hum) (13, 17). 

Phrase: "The protein-protein interaction of HSP-90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0872079:Protein-Protein Interaction [Molecular Function]
           interaction protein
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1704675:Interaction [Functional Concept]

Phrase: "with eNOS acutely"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   884   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0014257:Endothelial [Tissue]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "regulates"

Phrase: "eNOS activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C1151383:nitric-oxide synthase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "can"

Phrase: "facilitate"

Phrase: "phosphorylation of S1177"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "(hum"

Phrase: ")"

Phrase: "(13,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.238: Reduced binding of HSP-90 to eNOS can produce an "uncoupled" enzyme, whereby the diminished synthesis of NO is exaggerated by an increased production of O2 (37). 

Phrase: "Reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "binding of HSP-90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   864   C1523546:heat shock protein binding [Molecular Function]
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   716   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "can"

Phrase: "produce"

Phrase: "an """

Phrase: "uncoupled"

Phrase: """ enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "whereby"

Phrase: "the diminished synthesis of NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1157570:nitric oxide synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "exaggerated by an increased production of O2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442801:Exaggerated [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.239: To determine the extent of HSP-90 association, eNOS was immunoprecipitated from the hearts of LZR and OZR, and the amount of bound HSP-90 was assessed by immunoblot. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the extent of HSP-90 association,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439792:Extent [Spatial Concept]

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "immunoprecipitated from the hearts of LZR"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0034719:Rats, Zucker [Mammal]
   744   C0018787:Hearts [Body Part, Organ, or Organ Component]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C2700303:Zucker [Mammal]
   734   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   711   C0301871:Immunoprecipitate [Immunologic Factor]
   711 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "the amount of bound HSP-90"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "assessed by immunoblot."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblot [Laboratory Procedure]
   790   C1516048:Assessed [Activity]
Processing 00000000.tx.240: There is no significant difference between LZR and OZR in the amount of HSP-90 bound to eNOS (Fig. 9). 

Phrase: "There"

Phrase: "is"

Phrase: "no significant difference between LZR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "OZR in the amount of HSP-90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0034719:Zucker rat [Mammal]
   754   C0299583:Obese Protein [Amino Acid, Peptide, or Protein,Hormone]
   754   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0028754:Obese [Disease or Syndrome]
   738   C0034693:Rat, NOS [Mammal]
   738   C0034721:Rat [Mammal]
   738   C2700303:Zucker [Mammal]

Phrase: "bound to eNOS"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   882   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   882   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   882   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   833   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0014257:Endothelial [Tissue]
   753   C0030015:oxide [Inorganic Chemical]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.241: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.242: 9. 

Phrase: "9."
Processing 00000000.tx.243: Protein-protein interactions between eNOS and HSP-90 are unchanged in OZR and LZR. 

Phrase: "Protein-protein interactions between eNOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0872079:Protein-Protein Interaction [Molecular Function]
           interactions protein
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   711   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "HSP-90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "are"

Phrase: "unchanged in OZR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]

Phrase: "and"

Phrase: "LZR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.244: eNOS was immunoprecipitated (IP) from hearts of LZR and OZR and immunoblotted for eNOS and bound HSP-90 (n = 3).   

Phrase: "eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "immunoprecipitated (IP) from hearts of LZR"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0034719:Rats, Zucker [Mammal]
   748   C0018787:Hearts [Body Part, Organ, or Organ Component]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C2700303:Zucker [Mammal]
   741   C1882687:Rat Heart [Body Part, Organ, or Organ Component]
   714   C0301871:Immunoprecipitate [Immunologic Factor]
   714 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "immunoblotted for eNOS"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   882   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   882   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   833   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0014257:Endothelial [Tissue]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "and"

Phrase: "bound HSP-90"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   937   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0282498:Heat Shock [Physiologic Function]
   804   C0018837:Heat [Natural Phenomenon or Process]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0036974:Shock [Pathologic Function]
   804   C0332297:bound [Spatial Concept]
   804   C0439083:>90 [Quantitative Concept]
   804   C0439087:<90 [Quantitative Concept]
   804   C1145667:Bound [Activity]
   804   C1167622:Bound [Molecular Function]
   804   C1689898:% bound [Quantitative Concept]
   804   C2349209:Bound [Conceptual Entity]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.245: DISCUSSION TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Insulin-resistant states represent an emerging risk factor in the development of vascular disease. 

Phrase: "DISCUSSION TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin-resistant states"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0332325:Resistant [Functional Concept]
   827   C1301808:states [Geographic Area]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C2827757:RESISTANT [Laboratory or Test Result]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an emerging risk factor in the development of vascular disease."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   795   C0850664:risk factor (of) disease [Finding]
           disease risk factor
   760   C0035648:Risk factor [Quantitative Concept]
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   757   C0679238:disease factor [Functional Concept]
   757   C1281905:disease risk [Finding]
   739   C0035647:Risk [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.246: Because many of the vasculopathies accelerated by insulin resistance and diabetes center around NO, we hypothesized that induction of insulin resistance would abrogate the expression or regulation of enzymes that generate NO. 

Phrase: "Because"

Phrase: "many of the vasculopathies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]

Phrase: "accelerated by insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C0521110:Accelerated [Functional Concept]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes center around NO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that induction of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "abrogate"

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "regulation of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "that"

Phrase: "generate"

Phrase: "NO."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.247: To test this hypothesis, we have employed four different models of insulin resistance, in vivo and in vitro. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "four different models of insulin resistance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Models [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.248: In OZR, endothelium-dependent vasodilation is significantly impaired and plasma levels of NO metabolites are reduced. 

Phrase: "In OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "endothelium-dependent vasodilation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0042401:Vasodilation [Physiologic Function]
   827   C0595862:VASODILATION [Pathologic Function]
   827   C3537065:Vasodilation [Physiologic Function]

Phrase: "is"

Phrase: "significantly"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "and"

Phrase: "plasma levels of NO metabolites"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.249: These data suggest that the ability of eNOS to deliver biologically active NO to target tissues is compromised in OZR. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ability of eNOS to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "deliver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "biologically active NO to target tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   795   C0040300:Tissues [Tissue]
   795   C1521840:Target [Functional Concept]
   795   C2986546:TARGET [Diagnostic Procedure]
   762 E C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "compromised in OZR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034719:Zucker rat [Mammal]
   760   C0028754:Obese [Disease or Syndrome]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C2700303:Zucker [Mammal]
   726   C2945640:compromise [Finding]
Processing 00000000.tx.250: However, eNOS protein levels are not significantly different in young vs. adult animals or across several tissues, including heart, aorta, and skeletal muscle. 

Phrase: "However,"

Phrase: "eNOS protein levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   793   C0428479:Protein level [Laboratory or Test Result]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "are"

Phrase: "not significantly different in young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "vs. adult animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0596888:adult animal [Animal]
   861   C0003062:Animals [Animal]

Phrase: "or across several tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0040300:Tissues [Tissue]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "heart,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "aorta,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003483:Aorta [Body Part, Organ, or Organ Component]
  1000   C1278934:Aorta [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.251: In addition, no significant differences in eNOS expression were found in other models of insulin resistance, namely, ob/ob mice, fructose-fed rats, and PTP-1B-overexpressing endothelial cells vs. their respective controls. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "no significant differences in eNOS expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "found in other models of insulin resistance,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0150312:Found [Quantitative Concept]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3161035:Models [Intellectual Product]
   714 E C0243095:Find [Finding]

Phrase: "namely,"

Phrase: "ob/ob mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "fructose-fed rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "PTP-1B-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "vs."

Phrase: "their respective controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.252: Our present study is the first to examine whether insulin resistance influences the posttranslational regulation of eNOS. 

Phrase: "Our present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "influences"

Phrase: "the posttranslational regulation of eNOS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514251:Post-Translational Regulation [Molecular Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.253: In OZR, the phosphorylation states of T494 [T495(hum)] and S632 [S633(hum)] are not significantly different, whereas the phosphorylation of S1176 [S1177(hum)] is slightly increased. 

Phrase: "In OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "the phosphorylation states of T494"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1301808:states [Geographic Area]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "[T495"

Phrase: "(hum"

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "S632"

Phrase: "[S633"

Phrase: "(hum"

Phrase: ")"

Phrase: "]"

Phrase: "are"

Phrase: "not significantly different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: "whereas"

Phrase: "the phosphorylation of S1176"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "[S1177"

Phrase: "(hum"

Phrase: ")"

Phrase: "]"

Phrase: "is"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.254: The protein-protein interaction between eNOS and HSP-90 was also unaffected by insulin resistance. 

Phrase: "The protein-protein interaction between eNOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0872079:Protein-Protein Interaction [Molecular Function]
           interaction protein
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "HSP-90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "was"

Phrase: "also unaffected by insulin resistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.255: Thus it appears that impaired endothelium-dependent relaxation or NO signaling in states of insulin resistance is not due to deficits in the synthesis of NO. 

Phrase: "Thus"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that impaired endothelium-dependent relaxation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0014257:Endothelium [Tissue]
   812   C0035028:Relaxation [Activity]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "or"

Phrase: "NO signaling in states of insulin resistance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1155501:nitric oxide signaling [Molecular Function]
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "not due to deficits"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C1518422:Not [Functional Concept]
   770   C2987487:deficits [Qualitative Concept]
   770   C3146286:Due [Idea or Concept]
   737 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "in the synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "of NO."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.256: It is therefore likely that other factors, such as the generation of O2-derived free radicals, changes in localization, or constraining concentrations of cofactors or substrates, are contributing to the dysfunction. 

Phrase: "It"

Phrase: "is"

Phrase: "therefore likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "other factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "such as the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of O2-derived free radicals,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   812   C0302912:radicals [Chemical Viewed Structurally]
   812   C0332296:free [Functional Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0439807:Radical [Qualitative Concept]

Phrase: "changes in localization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C0475264:Localisation [Functional Concept]
   790   C1705241:Change [Quantitative Concept]
   790   C1744691:localisation [Biologic Function]

Phrase: "or"

Phrase: "constraining concentrations of cofactors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "or"

Phrase: "substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "contributing to the dysfunction."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1880177:Contributing [Activity]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.257: The study of insulin resistance is complicated by the fact that, in the clinical setting, the condition rarely presents alone but, most commonly, occurs in the context of obesity and the metabolic syndrome X. 

Phrase: "The study of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "complicated by the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0231242:Complicated [Functional Concept]

Phrase: "that,"

Phrase: "in the clinical setting,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3176918:Clinical setting [Spatial Concept]
   861   C0542559:setting [Functional Concept]
   861   C1318139:{Setting} [Quantitative Concept]

Phrase: "the condition rarely"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "but"

Phrase: ","

Phrase: "most commonly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "occurs in the context of obesity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0028754:Obesity [Disease or Syndrome]
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]
   753   C1709305:Occur [Activity]
   753   C1963185:Obesity [Finding]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "the metabolic syndrome X."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524620:Metabolic Syndrome X [Disease or Syndrome]
           Metabolic syndrome
   901   C0206064:syndrome x [Disease or Syndrome]
Processing 00000000.tx.258: These coincident risk factors may obscure the effects of insulin resistance as an independent variable on vascular function. 

Phrase: "These coincident risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   827   C0035647:Risk [Qualitative Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "obscure"

Phrase: "the effects of insulin resistance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "as an independent variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "on vascular function."
Meta Candidates (Total=18; Excluded=10; Pruned=0; Remaining=8)
  1000   C0232337:Vascular function [Clinical Attribute]
   950 E C0005811:blood function [Organ or Tissue Function]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1558950:VASCULAR [Finding]
   861   C1705273:Function [Intellectual Product]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.259: In this study, we have addressed this issue by comparing four different strategies to invoke insulin resistance. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "this issue by comparing four different strategies to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0033213:Issue [Finding]
   744   C1706387:Issue [Intellectual Product]

Phrase: "invoke"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.260: We first used the traditional OZR model, which develops insulin resistance secondary to leptin resistance and obesity (3, 24). 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the traditional OZR model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "which"

Phrase: "develops"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "secondary to leptin resistance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0175668:Secondary to [Temporal Concept]
           Secondary
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]

Phrase: "and"

Phrase: "obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.261: This model most closely describes the insulin resistance that manifests in patient populations. 

Phrase: "This model most closely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "describes"

Phrase: "the insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that"

Phrase: "manifests in patient populations."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:*^patient [Patient or Disabled Group]
   770   C0032659:Population [Quantitative Concept]
   770   C0205319:Manifest [Functional Concept]
   770   C1257890:Population [Population Group]
Processing 00000000.tx.262: A common criticism of this model is that the competing effects of obesity and hypertension in these animals obscure the direct consequences of insulin resistance. 

Phrase: "A common criticism of this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0870379:criticism [Social Behavior]

Phrase: "is"

Phrase: "that"

Phrase: "the competing effects of obesity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "hypertension in these animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020538:Hypertension [Disease or Syndrome]
   770   C1963138:Hypertension [Finding]

Phrase: "obscure"

Phrase: "the direct consequences of insulin resistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0686907:Consequence of [Functional Concept]
           consequences
Processing 00000000.tx.263: To address this, we also used the fructose-fed rat model, which develops insulin resistance secondary to elevated sugar consumption, allowing the examination of insulin resistance without the potentially confounding effects of obesity (25). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this,"

Phrase: "we also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the fructose-fed rat model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]

Phrase: "which"

Phrase: "develops"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "secondary to elevated sugar consumption,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0175668:Secondary to [Temporal Concept]
           Secondary
   760   C0027627:secondary [Neoplastic Process]
   760   C0205436:Secondary [Quantitative Concept]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "the examination of insulin resistance"

Phrase: "without the potentially confounding effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "of obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.264: Third, we employed the ob/ob mouse (22), which presents with obesity and insulin resistance, but not the leptin resistance in OZR. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "we"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "the ob/ob mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "presents with obesity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
   790   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the leptin resistance in OZR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
Processing 00000000.tx.265: A final model of insulin resistance was generated in vitro in endothelial cells and excludes the in vivo complications of metabolic, hormonal, and hemodynamic forces. 

Phrase: "A final model of insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "in vitro in endothelial cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "excludes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the in vivo complications of metabolic, hormonal,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0009566:Complications [Pathologic Function]
   748   C1171258:complications [Pathologic Function]
   714 E C2362589:Complication [Idea or Concept]

Phrase: "and"

Phrase: "hemodynamic forces."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0441722:forces [Phenomenon or Process]
   827 E C0563538:Force [Phenomenon or Process]
   789 E C0729333:Dynamic [Functional Concept]
Processing 00000000.tx.266: In our present study, none of these animals or cells displayed reductions in eNOS expression or regulation. 

Phrase: "In our present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "none of these animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003062:Animals [Animal]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "reductions in eNOS expression"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0301630:reductions [Natural Phenomenon or Process]
   748   C0441610:reductions [Therapeutic or Preventive Procedure]
   714 E C0392756:Reduction [Qualitative Concept]

Phrase: "or"

Phrase: "regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.267: This finding provides strong evidence that eNOS is resistant to detrimental effects of insulin resistance, regardless of how insulin resistance is presented. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "is"

Phrase: "resistant to detrimental effects of insulin resistance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332325:Resistant to [Functional Concept]
           Resistant
   748   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "regardless of how insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "presented."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.268: An interdependent relation exists between insulin and eNOS signaling. 

Phrase: "An interdependent relation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0080103:Relation [Family Group]
   861   C0869014:relation [Social Behavior]
   789 E C0439849:Related [Qualitative Concept]
   789 E C0445223:Related [Finding]

Phrase: "exists between insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C2987476:Exist [Conceptual Entity]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "eNOS signaling."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   888   C1155501:nitric oxide signaling [Molecular Function]
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.269: eNOS-derived NO has been proposed to facilitate glucose uptake into liver and skeletal muscle, a phenomenon emphasized by the insulin-resistant phenotype of mice with homozygous deletion of eNOS (7, 41). 

Phrase: "eNOS-derived NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   710   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "glucose uptake into liver"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1159527:glucose uptake [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "skeletal muscle,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "a phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "emphasized by the insulin-resistant phenotype of mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0031437:Phenotype [Organism Attribute]
   744   C0332325:Resistant [Functional Concept]
   744   C1285572:Phenotype [Laboratory Procedure]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "with homozygous deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "of eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(7,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.270: Conversely, insulin has been proposed as a major regulator of eNOS protein expression. 

Phrase: "Conversely,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "proposed as a major regulator of eNOS protein expression."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   790   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   785   C1526988:nitric-oxide synthase regulator [Molecular Function]
   770   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   753   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C1171362:protein expression [Genetic Function]
   751   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   736   C0014257:Endothelial [Tissue]
   736   C0030015:oxide [Inorganic Chemical]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0182953:REGULATOR [Medical Device]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205164:Major [Qualitative Concept]
   736   C1441414:PROPOSED [Idea or Concept]
   736   C1553874:Proposed [Qualitative Concept]
   736   C1578820:Proposed [Idea or Concept]
   736   C1704734:Regulator [Medical Device]
   736   C1704735:Regulator [Conceptual Entity]
   736   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.271: In animal models of insulin resistance and specific deletion of endothelial insulin receptors, reduced expression of eNOS mRNA has been reported (28, 50). 

Phrase: "In animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "of insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "specific deletion of endothelial insulin receptors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "reduced expression of eNOS mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1515670:mRNA Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(28,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.272: Exogenous insulin has also been shown to increase eNOS expression (9, 28). 

Phrase: "Exogenous insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "eNOS expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(9,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.273: However, in our present study, we find that insulin resistance does not decrease eNOS expression. 

Phrase: "However,"

Phrase: "in our present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "eNOS expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.274: Although the majority of studies reporting a decrease have investigated only eNOS mRNA levels (28, 50), the differences between our study and others showing reduced levels of eNOS protein are not readily explained. 

Phrase: "Although"

Phrase: "the majority of studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "reporting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0700287:Reporting [Health Care Activity]
   966 E C0684224:Report [Intellectual Product]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "only eNOS mRNA levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   795   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0441889:Levels [Qualitative Concept]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]
   710   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "(28,"

Phrase: "50"

Phrase: ")"

Phrase: ","

Phrase: "the differences between our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "reduced levels of eNOS protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "not readily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "explained."
Processing 00000000.tx.275: In the present study, we have used four different models of insulin resistance and three different vascular beds and have measured mRNA and protein levels without significant differences. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "four different models of insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "three different vascular beds"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   827   C0598051:vascular bed [Body Part, Organ, or Organ Component]
   812   C0004916:Beds [Manufactured Object]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   779 E C0596170:BED [Mental or Behavioral Dysfunction]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "and"

Phrase: "have"

Phrase: "measured mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "protein levels without significant differences."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C0428479:Protein level [Laboratory or Test Result]
   762   C0814896:levels significance [Research Activity]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.276: More recent studies in ob/ob mice, OZR, and fructose-fed rats support our findings and have not observed a reduction in eNOS protein or mRNA expression (27, 34, 40). 

Phrase: "More recent studies in ob/ob mice,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "and"

Phrase: "fructose-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "and"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a reduction in eNOS protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515670:mRNA Expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(27,"

Phrase: "34,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.277: Another possibility is that the local concentration of eNOS may be altered. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the local concentration of eNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "altered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]
Processing 00000000.tx.278: A recent study using diabetic rats showed no difference in the level of eNOS protein and mRNA isolated from total hearts; 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no difference in the level of eNOS protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1705241:*Difference [Quantitative Concept]
   738   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "isolated from total hearts"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0018787:Hearts [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1281570:Heart [Body Part, Organ, or Organ Component]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.279: however, reduced levels of eNOS were found in select vessels via immunohistochemistry (10). 

Phrase: "however,"

Phrase: "reduced levels of eNOS"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "found in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0150312:Found [Quantitative Concept]
   799 E C0243095:Find [Finding]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "vessels via immunohistochemistry"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0005847:Vessels [Body Part, Organ, or Organ Component]
   756 E C1511228:Vessel [Tissue]
   718 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.280: Reduced endothelium-dependent relaxation is a hallmark of insulin resistance; 

Phrase: "Reduced endothelium-dependent relaxation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0014257:Endothelium [Tissue]
   812   C0035028:Relaxation [Activity]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "is"

Phrase: "a hallmark of insulin resistance"

Phrase: ";"
Processing 00000000.tx.281: yet very little is known about the consequences of insulin resistance in the acute, posttranslational regulation of eNOS. 

Phrase: "yet very little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   827   C0700321:Little [Quantitative Concept]
   827   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the consequences of insulin resistance"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   762   C0686907:Consequence of [Functional Concept]
           consequences
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205309:Known [Qualitative Concept]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in the acute, posttranslational regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1514251:Post-Translational Regulation [Molecular Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "of eNOS."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.282: In addition to calcium-calmodulin, eNOS activity is influenced by its subcellular localization, phosphorylation state, and protein-protein interactions (11, 16). 

Phrase: "In addition to calcium-calmodulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006772:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1366910:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "eNOS activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C1151383:nitric-oxide synthase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "influenced by its subcellular localization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "phosphorylation state,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "protein-protein interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704675:Interaction [Functional Concept]

Phrase: "(11,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.283: In isolated activity assays, the attenuated function of eNOS extracted from the tissues of fructose-fed animals hints at compromised posttranslational regulation (31, 42). 

Phrase: "In isolated activity assays,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "the attenuated function of eNOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "extracted from the tissues of fructose-fed animals"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   750   C0229982:animal tissues [Tissue]
   744   C0003062:Animals [Animal]
   744   C0016745:Fructose [Carbohydrate,Pharmacologic Substance]
   744   C0040300:Tissues [Tissue]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C0342895:FED [Disease or Syndrome]
   744   C3541890:EXTRACTED [Finding]
   734   C0003050:Animal Feed [Food]
   734   C0596095:animal extract [Biologically Active Substance,Organic Chemical]
   711 E C0204695:Feed [Health Care Activity]
   711 E C1547928:Tissue [Intellectual Product]
   711 E C2828366:Extract [Substance]
   711 E C2987508:Feed [Activity]

Phrase: "hints at compromised posttranslational regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1514251:Post-Translational Regulation [Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   760   C1415545:HINT [Gene or Genome]
   760   C1512348:HINTS [Intellectual Product]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.284: However, such assays do not account for changes in subcellular localization or the intracellular milieu, i.e., reduced levels of cofactors or substrates. 

Phrase: "However,"

Phrase: "such assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "account for changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in subcellular localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "or"

Phrase: "the intracellular milieu,"

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "reduced levels of cofactors"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.285: Phosphorylation of specific sites on eNOS has been proposed to acutely regulate eNOS activity positively and negatively. 

Phrase: "Phosphorylation of specific sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1519063:Phosphorylation Site [Amino Acid Sequence]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "on eNOS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to acutely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "eNOS activity positively"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1151383:nitric-oxide synthase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   734   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "and"

Phrase: "negatively."
Processing 00000000.tx.286: Phosphorylation of bovine eNOS has been reported on S116, T497, S617, S635, and S1179 (2 aa in the human gene and 3 aa in the rat and mouse) (11). 

Phrase: "Phosphorylation of bovine eNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "reported on S116,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "T497,"

Phrase: "S617,"

Phrase: "S635,"

Phrase: "and"

Phrase: "S1179"

Phrase: "(2 aa in the human gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1235746:Aa [Plant]
   753   C1882141:aa [Qualitative Concept]

Phrase: "and"

Phrase: "3 aa in the rat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0444860:Aa 3 [Intellectual Product]
   760   C1235746:Aa [Plant]
   760   C1882141:aa [Qualitative Concept]

Phrase: "and"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: ")"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.287: Additionally, rat eNOS contains a substitution at T113, equivalent to S114 on the human gene. 

Phrase: "Additionally,"

Phrase: "rat eNOS"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1565682:endothelial nitric oxide synthase, rat [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   884   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   840   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0014257:Endothelial [Tissue]
   804   C0030015:oxide [Inorganic Chemical]
   804   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a substitution at T113,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1555721:Substitution [Idea or Concept]
   770   C1706204:Substitution [Activity]

Phrase: "equivalent to S114"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205163:Equivalent [Qualitative Concept]
   790   C0439185:equivalent [Quantitative Concept]

Phrase: "on the human gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0314604:Human gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.288: The phosphorylation of S1176 [S1177(hum)] occurs in a time frame consistent with NO release and increases the calcium sensitivity and specific activity of the enzyme. 

Phrase: "The phosphorylation of S1176"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "[S1177"

Phrase: "(hum"

Phrase: ")"

Phrase: "]"

Phrase: "occurs in a time frame"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0332168:Time frame [Temporal Concept]
   806   C0872291:Time Frame [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0080089:Frame [Nucleotide Sequence]
   760   C0180979:Frame [Medical Device]
   760   C1705858:Frame [Manufactured Object]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "consistent with NO release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the calcium sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "specific activity of the enzyme."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0243102:enzyme activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1552740:specific [Intellectual Product]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.289: Phosphorylation of this residue is stimulated by a variety of agonists, including shear stress, and is dependent on the correct subcellular targeting of the enzyme to peripheral aspects of the Golgi and plasma membrane (16). 

Phrase: "Phosphorylation of this residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "stimulated by a variety of agonists,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243192:agonists [Pharmacologic Substance]
   753   C1883525:Variety [Conceptual Entity]
   753   C1948023:Stimulated [Natural Phenomenon or Process]
   753   C2346866:Variety [Conceptual Entity]
   753   C2987634:agonists [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "shear stress,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1171318:shear stress [Natural Phenomenon or Process]
   861   C0038435:Stress [Finding]
   861   C0175735:shear [Medical Device]
   861   C0205013:shear [Therapeutic or Preventive Procedure]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "dependent on the correct subcellular targeting of the enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0851827:Dependent [Qualitative Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]

Phrase: "to peripheral aspects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547011:Aspect [Quantitative Concept]
   827   C1879746:Aspect [Qualitative Concept]

Phrase: "of the Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "and"

Phrase: "plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.290: In OZR, we observed an increase in S1176 [S1177(hum)] phosphorylation vs. control. 

Phrase: "In OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an increase in S1176"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "[S1177"

Phrase: "(hum"

Phrase: ")"

Phrase: "] phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "vs. control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.291: The exact mechanisms underlying the increase in phosphorylation are not known. 

Phrase: "The exact mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the increase in phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.292: However, no significant increase in phosphorylation was observed in the two other animal models of insulin resistance, suggesting that other perturbations in OZR mediate the increase in phosphorylation. 

Phrase: "However,"

Phrase: "no significant increase in phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed in the two"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205448:Two [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "other animal models of insulin resistance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599779:Models, Animal [Animal]
   753   C0003062:Animal [Animal]
   753   C3161035:Models [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other perturbations in OZR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0332453:perturbation [Functional Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the increase in phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]
Processing 00000000.tx.293: In addition, other studies have shown that high glucose does not affect eNOS phosphorylation at this residue (38) or results in decreased phosphorylation via O-linked glycosylation (8). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "eNOS phosphorylation at this residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "(38"

Phrase: ")"

Phrase: "or"

Phrase: "results in decreased phosphorylation"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "via O-linked glycosylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017982:glycosylation [Natural Phenomenon or Process]
   827   C0376322:Glycosylation [Molecular Function]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.294: We next addressed whether insulin resistance influences phosphorylation of eNOS at other residues. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "whether"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "influences"

Phrase: "phosphorylation of eNOS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "at other residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.295: Phosphorylation of T495 reduces eNOS activity through reduced calmodulin association and increased O2 production (12, 18, 29). 

Phrase: "Phosphorylation of T495"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "reduces"

Phrase: "eNOS activity through reduced calmodulin association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C1151383:nitric-oxide synthase activity [Molecular Function]
   762   C0086439:Reduced Activity [Sign or Symptom]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "increased O2 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "(12,"

Phrase: "18,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.296: S633 phosphorylation of eNOS increases eNOS activity in cultured cells and in enzyme activity assays (2, 32). 

Phrase: "S633 phosphorylation of eNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "eNOS activity in cultured cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1151383:nitric-oxide synthase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "and in enzyme activity assays"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0243102:enzyme activity [Molecular Function]
   797   C2717977:Enzyme Assays [Laboratory Procedure]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1515981:And [Idea or Concept]
   760   C1561536:*Activity [Idea or Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.297: There was no significant difference in the level of eNOS PO4 at T494 [T495(hum)] or S632 [S633(hum)] in OZR vs. lean controls. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in the level of eNOS PO4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]

Phrase: "at T494"

Phrase: "[T495"

Phrase: "(hum"

Phrase: ")"

Phrase: "]"

Phrase: "or"

Phrase: "S632"

Phrase: "[S633"

Phrase: "(hum"

Phrase: ")"

Phrase: "]"

Phrase: "in OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "vs. lean controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.298: Taken together, there is no evidence to suggest that alterations in eNOS phosphorylation mediate the reduced activity of eNOS observed in OZR. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "there"

Phrase: "is"

Phrase: "no evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that alterations in eNOS phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1515926:Alteration [Idea or Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the reduced activity of eNOS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   822   C1151383:nitric-oxide synthase activity [Molecular Function]
   770   C0086439:Reduced Activity [Sign or Symptom]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "observed in OZR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034719:Zucker rat [Mammal]
   760   C0028754:Obese [Disease or Syndrome]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1441672:Observed [Functional Concept]
   760   C2700303:Zucker [Mammal]
Processing 00000000.tx.299: The reduced association of eNOS with HSP-90 underlies the impaired vascular responses in hypercholesterolemia (36) and results in an uncoupled eNOS that produces excess O2 in preference to NO (37). 

Phrase: "The reduced association of eNOS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with HSP-90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "underlies"

Phrase: "the impaired vascular responses in hypercholesterolemia"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "(36"

Phrase: ")"

Phrase: "and"

Phrase: "results in an uncoupled eNOS"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   800   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   770   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0014257:Endothelial [Tissue]
   744   C0030015:oxide [Inorganic Chemical]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "that"

Phrase: "produces"

Phrase: "excess O2 in preference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "to NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.300: Little is known about the impact of insulin resistance on the balance of HSP-90-eNOS interactions. 

Phrase: "Little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the impact of insulin resistance"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0021655:Insulin Resistance [Pathologic Function]
   778   C2700570:INSULIN RESISTANCE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205309:Known [Qualitative Concept]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "on the balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014653:Balance [Organism Function]
  1000   C0205415:Balance [Functional Concept]
  1000   C0560184:Balance [Finding]

Phrase: "of HSP-90-eNOS interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   850   C0872079:protein interaction [Molecular Function]
   758   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.301: Recently, Stalker et al. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Stalker et al."
Processing 00000000.tx.302: (45) described reduced association of HSP-90 and eNOS in a rat model of hyperglycemia. 

Phrase: "(45"

Phrase: ")"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "reduced association of HSP-90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "eNOS in a rat model of hyperglycemia."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   824   C1565682:endothelial nitric oxide synthase, rat [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   782   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   760   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0014257:Endothelial [Tissue]
   739   C0030015:oxide [Inorganic Chemical]
   739   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.303: However, in our studies, we did not observe a decrease in HSP-90 binding, suggesting that insulin resistance in itself may be insufficient and that frank diabetes may be required to disrupt the eNOS-HSP-90 complex. 

Phrase: "However,"

Phrase: "in our studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "a decrease in HSP-90 binding,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin resistance in itself"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "insufficient"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205412:Insufficient [Qualitative Concept]
  1000   C0231180:Insufficient [Qualitative Concept]
   928 E C0231179:Insufficiency [Functional Concept]

Phrase: "and"

Phrase: "that frank diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the eNOS-HSP-90 complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   817   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   817   C1523872:protein complex [Cell Component]
   791   C0439855:Complex [Qualitative Concept]
   791   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.304: Having found no perturbations in the expression or posttranslational regulation of eNOS, we were surprised that insulin resistance could, under the right conditions, reduce NO release. 

Phrase: "Having"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no perturbations in the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332453:perturbation [Functional Concept]

Phrase: "or"

Phrase: "posttranslational regulation of eNOS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1514251:Post-Translational Regulation [Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "we"

Phrase: "were"

Phrase: "surprised"

Phrase: "that insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: ","

Phrase: "under the right conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "reduce"

Phrase: "NO release."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.305: In isolated endothelial cells that overexpress PTP-1B, which selectively negates insulin signaling, the ability of insulin to produce NO was abolished (Fig. 6C). 

Phrase: "In isolated endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "PTP-1B,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "which selectively"

Phrase: "negates"

Phrase: "insulin signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "produce"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "abolished"

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.306: However, in response to other stimuli, the overall capacity to generate NO was not affected. 

Phrase: "However,"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to other stimuli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimuli [Phenomenon or Process]

Phrase: "the overall capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "generate"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.307: These data demonstrate that the state of insulin resistance in endothelial cells per se does not necessarily reduce the capacity of these cells to produce NO. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the state of insulin resistance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]

Phrase: "in endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "per se"

Phrase: "does"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reduce"

Phrase: "the capacity of these cells to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "produce"

Phrase: "NO."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.308: In vivo, the overall contribution of insulin to NO release is not known, but it is likely to be overshadowed by other factors, such as shear stress, bradykinin, and other humoral agents. 

Phrase: "In vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the overall contribution of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to NO release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "overshadowed by other factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "such as shear stress,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1171318:shear stress [Natural Phenomenon or Process]
   861   C0038435:Stress [Finding]
   861   C0175735:shear [Medical Device]
   861   C0205013:shear [Therapeutic or Preventive Procedure]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "bradykinin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006100:Bradykinin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1537501:bradykinin [Gene or Genome]

Phrase: "and"

Phrase: "other humoral agents."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.309: In plasma samples from OZR, there was a significant reduction in the level of NO2 relative to plasma samples from LZR, suggesting reduced in vivo synthesis of NO in OZR. 

Phrase: "In plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444263:Plasma sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "from OZR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "there"

Phrase: "was"

Phrase: "a significant reduction in the level of NO2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "relative to plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "from LZR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "reduced in vivo synthesis of NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1157570:nitric oxide synthesis [Molecular Function]
   748   C0220781:synthesis [Biologic Function]
   748   C1883254:Synthesis [Activity]

Phrase: "in OZR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.310: However, the ability of NO2 to track in vivo NO production is controversial, and NO3, because of its longer half-life, is reputedly a better indicator of in vivo NO production (53). 

Phrase: "However,"

Phrase: "the ability of NO2 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "track"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040594:Track [Manufactured Object]

Phrase: "in vivo NO production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "controversial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "and"

Phrase: "NO3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919442:NO3 [Gene or Genome]
  1000   C1705347:NO3 [Gene or Genome]

Phrase: "because of its longer half-life,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0018517:Half-Life [Temporal Concept]
   827   C0376558:Life [Idea or Concept]
   827   C2825407:Half [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "is"

Phrase: "reputedly"

Phrase: "a better indicator of in vivo NO production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   742   C1235732:Indicator [Bird]
   742   C1522602:Indicator [Functional Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.311: The level of NO3 in plasma from OZR was reduced but not significantly different from that in plasma from LZR. 

Phrase: "The level of NO3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "in plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "from OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "but"

Phrase: "not significantly different from that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "in plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "from LZR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0034719:Rats, Zucker [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700303:Zucker [Mammal]
Processing 00000000.tx.312: One possible explanation for these findings is that the level of NO3 in OZR may be artificially elevated because of excessive food consumption (23). 

Phrase: "One possible explanation for these findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "the level of NO3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "in OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "may"

Phrase: "be"

Phrase: "artificially"

Phrase: "elevated because of excessive food consumption"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2983605:Food Consumption [Activity]
   753   C0009830:Consumption [Activity]
   753   C0016452:Food [Food]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0442802:Excessive [Qualitative Concept]
   753   C1947907:Consumption [Physiologic Function]
   753   C3163633:Elevated [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.313: On the basis of the evidence presented in these studies, impaired endothelium-dependent relaxation in OZR cannot be attributed to decreased expression or impaired posttranslational modification of eNOS. 

Phrase: "On the basis of the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "presented in these studies,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0150312:Present [Quantitative Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "impaired endothelium-dependent relaxation in OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0014257:Endothelium [Tissue]
   744   C0035028:Relaxation [Activity]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "attributed to decreased expression"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737   C0449234:Attribute [Idea or Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "or"

Phrase: "impaired posttranslational modification of eNOS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033666:Post-Translational Modification [Molecular Function]
   744   C0392747:Modification [Functional Concept]
   744   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.314: However, we do observe reduced NO2 in plasma samples of OZR, suggesting that the in vivo generation of NO is compromised. 

Phrase: "However,"

Phrase: "we"

Phrase: "do"

Phrase: "observe"

Phrase: "reduced NO2 in plasma samples of OZR,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the in vivo generation of NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "is"

Phrase: "compromised."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]
Processing 00000000.tx.315: Previous studies have shown that antioxidants can partially restore endothelium-dependent relaxation in the Zucker rat (14), suggesting that additional mechanisms are responsible for the vascular dysfunction. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "can"

Phrase: "partially"

Phrase: "restore"

Phrase: "endothelium-dependent relaxation in the Zucker rat"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0014257:Endothelium [Tissue]
   748   C0035028:Relaxation [Activity]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that additional mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "responsible for the vascular dysfunction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.316: The source of the excessive intravascular production of O2 in the OZR is not known. 

Phrase: "The source of the excessive intravascular production of O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449416:Source [Finding]
   742   C1705919:Source [Idea or Concept]

Phrase: "in the OZR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0034719:Zucker rat [Mammal]
   827   C0028754:Obese [Disease or Syndrome]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.317: However, in light of our present data showing no change in HSP-90 association or phosphorylation of T494 [T495(hum)], it is unlikely to derive from "uncoupled" eNOS. 

Phrase: "However,"

Phrase: "in light of our present data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no change in HSP-90 association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442739:No change [Finding]
   770   C1548568:No change [Intellectual Product]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "phosphorylation of T494"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "[T495"

Phrase: "(hum"

Phrase: ")"

Phrase: "],"

Phrase: "it"

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "derive from """

Phrase: "uncoupled"

Phrase: """ eNOS."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.318: Additional mechanisms underlying vascular dysfunction include reduced levels of tetrahydrobiopterin or upregulation of NADPH oxidases (NOXs). 

Phrase: "Additional mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "vascular dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "reduced levels of tetrahydrobiopterin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "upregulation of NADPH oxidases (NOXs)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]
Processing 00000000.tx.319: Future studies to identify the source of intravascular O2 may provide an avenue for therapeutic intervention and, eventually, improvement in vascular function in diabetes and insulin resistance.  

Phrase: "Future"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016884:Future [Temporal Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the source of intravascular O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an avenue for therapeutic intervention"

Phrase: "and"

Phrase: ","

Phrase: "eventually,"

Phrase: "improvement in vascular function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986411:Improvement [Conceptual Entity]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.320: GRANTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  This work was supported by National Heart, Lung, and Blood Institute Grants R01 HL-074279-01 (D. Fulton) and R01 HL-067303 (D. W. Stepp) and American Heart Association Grants SDG 0330196N (D. Fulton) and SDG 0030370Z (D. W. Stepp).  

Phrase: "GRANTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Heart,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0018787:Heart [Body Part, Organ, or Organ Component]
   770   C1281570:Heart [Body Part, Organ, or Organ Component]
   770   C1521721:Supported [Conceptual Entity]
   770   C3245503:national [Intellectual Product]
   737 E C0183683:Support [Medical Device]

Phrase: "Lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "Blood Institute Grants R01 HL-074279-01"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   795   C0005767:Blood [Tissue]
   795   C0005768:blood [Body Substance]
   795   C0018173:Grants [Quantitative Concept]
   795   C0021622:institute [Organization]
   795   C0229664:Blood [Body Substance]
   795   C1272753:Institute [Idea or Concept]
   795   C1549838:R01 [Intellectual Product]
   762 E C1548284:Grant [Idea or Concept]
   724 E C0333275:Bloody [Qualitative Concept]
   712 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   712 E C0392895:Bloods [Population Group]
   712 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   712 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "(D. Fulton"

Phrase: ")"

Phrase: "and"

Phrase: "R01 HL-067303"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1549838:R01 [Intellectual Product]

Phrase: "(D. W. Stepp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1538755:STEPP [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "American Heart Association Grants SDG 0330196N"

Phrase: "(D. Fulton"

Phrase: ")"

Phrase: "and"

Phrase: "SDG 0030370Z"

Phrase: "(D. W. Stepp"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1538755:STEPP [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.321: ACKNOWLEDGMENTS  We thank James Mintz and Julie Campbell for technical assistance.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "James Mintz"

Phrase: "and"

Phrase: "Julie Campbell for technical assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0331936:Campbell [Health Care Related Organization]
Processing 00000000.tx.322: FOOTNOTES  Address for reprint requests and other correspondence: D. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "D."
Processing 00000000.tx.323: Fulton, Vascular Biology Center, Medical College of Georgia, 1459 Laney Walker Blvd., Augusta, GA 30912 (E-mail: dfulton{at}mcg.edu ) The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "Fulton,"

Phrase: "Vascular Biology Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "Medical College of Georgia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "1459 Laney Walker Blvd.,"

Phrase: "Augusta,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1189407:Augusta [Plant]

Phrase: "GA 30912"

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "dfulton{at}mcg.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.324: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.325: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.326: REFERENCES TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, and Haring HU. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Balletshofer BM,"

Phrase: "Rittig K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Enderle MD,"

Phrase: "Volk A,"

Phrase: "Maerker E,"

Phrase: "Jacob S,"

Phrase: "Matthaei S,"

Phrase: "Rett K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Haring HU."
Processing 00000000.tx.327: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. 

Phrase: "Endothelial dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0856169:endothelial dysfunction [Disease or Syndrome]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "detectable in young normotensive first-degree relatives of subjects"

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.328: Circulation 101: 17801784, 2000.[Abstract/Free FullText] Boo YC, Sorescu GP, Bauer PM, Fulton D, Kemp BE, Harrison DG, Sessa WC, and Jo H. 

Phrase: "Circulation 101"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "17801784,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Boo YC,"

Phrase: "Sorescu GP,"

Phrase: "Bauer PM, Fulton D,"

Phrase: "Kemp"

Phrase: "BE"

Phrase: ","

Phrase: "Harrison DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Sessa WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "and"

Phrase: "Jo H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.329: Endothelial NO synthase phosphorylated at Ser635 produces NO without requiring intracellular calcium increase. 

Phrase: "Endothelial NO synthase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "phosphorylated at Ser635"

Phrase: "produces"

Phrase: "NO without requiring intracellular calcium increase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   774   C0064990:Calcium oxide [Inorganic Chemical,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.330: Free Radic Biol Med 35: 729741, 2003.[CrossRef][ISI][Medline] Bray GA. 

Phrase: "Free Radic Biol Med 35"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "729741,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bray GA."
Processing 00000000.tx.331: The Zucker-fatty rat: a review. 

Phrase: "The Zucker-fatty rat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0034719:Zucker rat [Mammal]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C2700303:Zucker [Mammal]

Phrase: ":"

Phrase: "a review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]
Processing 00000000.tx.332: Fed Proc 36: 148153, 1977.[ISI][Medline] Byon JC, Kusari AB, and Kusari J. 

Phrase: "Fed Proc 36"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0342895:FED [Disease or Syndrome]
   827   C1418943:PROC [Gene or Genome]
   793 E C0204695:Feed [Health Care Activity]
   793 E C2987508:Feed [Activity]

Phrase: ":"

Phrase: "148153,"

Phrase: "1977."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Byon JC,"

Phrase: "Kusari AB,"

Phrase: "and"

Phrase: "Kusari J."
Processing 00000000.tx.333: Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. 

Phrase: "Protein-tyrosine phosphatase-1B"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0908145:Protein Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335056:Protein-Tyrosine Phosphatase 1B [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0085536:Protein Tyrosine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           tyrosine phosphatase
   875   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0450345:1B [Intellectual Product]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "acts as a negative regulator of insulin signal transduction."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   784   C3271725:negative signal transduction [Cell Function]
   764   C0037083:Signal Transduction [Cell Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0079613:ACT [Therapeutic or Preventive Procedure]
   742   C0182953:REGULATOR [Medical Device]
   742   C0205160:Negative [Qualitative Concept]
   742   C1160185:transduction [Organism Function]
   742   C1513916:Negative [Finding]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1704734:Regulator [Medical Device]
   742   C1704735:Regulator [Conceptual Entity]
   742   C1710082:Signal [Phenomenon or Process]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.334: Mol Cell Biochem 182: 101108, 1998.[CrossRef][ISI][Medline] Crouse JA, Elliott GE, Burgess TL, Chiu L, Bennett L, Moore J, Nicolson M, and Pacifici RE. 

Phrase: "Mol Cell Biochem 182"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "101108,"

Phrase: "1998."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Crouse JA,"

Phrase: "Elliott GE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538705:GE [Gene or Genome]

Phrase: "Burgess TL,"

Phrase: "Chiu L,"

Phrase: "Bennett L,"

Phrase: "Moore J,"

Phrase: "Nicolson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Pacifici RE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]
Processing 00000000.tx.335: Altered cell surface expression and signaling of leptin receptors containing the fatty mutation. 

Phrase: "Altered cell surface expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0699040:Cell surface [Cell Component]
   812   C0007634:Cell [Cell]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0205148:Surface [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "signaling of leptin receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1514762:Receptor Signaling [Molecular Function]
   770   C0037083:Signaling [Cell Function]
   770   C3537152:signaling [Biologic Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the fatty mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.336: J Biol Chem 273: 1836518373, 1998.[Abstract/Free FullText] Ding Y, Vaziri ND, Coulson R, Kamanna VS, and Roh DD. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1836518373,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ding Y,"

Phrase: "Vaziri ND,"

Phrase: "Coulson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kamanna"

Phrase: "VS"

Phrase: ","

Phrase: "and"

Phrase: "Roh DD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]
Processing 00000000.tx.337: Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. 

Phrase: "Effects of simulated hyperglycemia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon on endothelial nitric oxide synthase expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.338: Am J Physiol Endocrinol Metab 279: E11E17, 2000.[Abstract/Free FullText] Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, and Scherrer U. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 279"

Phrase: ":"

Phrase: "E11E17,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Duplain H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Burcelin R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sartori C,"

Phrase: "Cook S,"

Phrase: "Egli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lepori M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vollenweider P,"

Phrase: "Pedrazzini T,"

Phrase: "Nicod P,"

Phrase: "Thorens B,"

Phrase: "and"

Phrase: "Scherrer U."
Processing 00000000.tx.339: Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. 

Phrase: "Insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "hyperlipidemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020473:Hyperlipidaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "hypertension in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020538:Hypertension [Disease or Syndrome]
   790   C1963138:Hypertension [Finding]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "endothelial nitric oxide synthase."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.340: Circulation 104: 342345, 2001.[Abstract/Free FullText] Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D, Sbraccia P, Spagnoli LG, Sesti G, and Lauro R. 

Phrase: "Circulation 104"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "342345,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Menghini R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mauriello A,"

Phrase: "Hribal ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Ferrelli F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lauro D,"

Phrase: "Sbraccia P,"

Phrase: "Spagnoli LG,"

Phrase: "Sesti G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Lauro R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.341: Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. 

Phrase: "Insulin-dependent activation of endothelial nitric oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "impaired by O-linked glycosylation modification of signaling proteins"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   801   C1621325:protein O-linked glycosylation [Molecular Function]
   781   C3552785:Impaired O-glycosylation [Finding]
   762   C0376322:glycosylation proteins [Molecular Function]
           Glycosylation
   748   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C0033666:Protein Modification [Molecular Function]
   745   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C2263112:protein modification [Molecular Function]
   742   C0017982:glycosylation [Natural Phenomenon or Process]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0037083:Signaling [Cell Function]
   742   C0221099:Impaired [Functional Concept]
   742   C0392747:Modification [Functional Concept]
   742   C0684336:Impaired [Pathologic Function]
   742   C1554963:modification [Qualitative Concept]
   742   C3537152:signaling [Biologic Function]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]
   708 E C1710082:Signal [Phenomenon or Process]

Phrase: "in human coronary endothelial cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.342: Circulation 106: 466472, 2002.[Abstract/Free FullText] Federici M, Pandolfi A, De Filippis EA, Pellegrini G, Menghini R, Lauro D, Cardellini M, Romano M, Sesti G, Lauro R, and Consoli A. 

Phrase: "Circulation 106"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "466472,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Federici M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pandolfi A,"

Phrase: "De Filippis EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   827   C1457900:EA [Quantitative Concept]

Phrase: "Pellegrini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Menghini R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lauro D,"

Phrase: "Cardellini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Romano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sesti G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lauro R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Consoli A."
Processing 00000000.tx.343: G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. 

Phrase: "G972R IRS-1 variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: "impairs"

Phrase: "insulin regulation of endothelial nitric oxide synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in cultured human endothelial cells."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   902   C0007600:cultured cells [Cell]
   902   C0007635:Cultured Cells [Cell]
   902   C3282338:Cells, Cultured [Cell]
   875   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C0086418:Human [Human]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.344: Circulation 109: 399405, 2004.[Abstract/Free FullText] Felaco M, Di Maio FD, De Fazio P, D'Arcangelo C, De Lutiis MA, Varvara G, Grilli A, Barbacane RC, Reale M, and Conti P. 

Phrase: "Circulation 109"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "399405,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Felaco M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Di Maio FD,"

Phrase: "De Fazio P,"

Phrase: "D'"

Phrase: "Arcangelo C,"

Phrase: "De Lutiis MA,"

Phrase: "Varvara G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Grilli A,"

Phrase: "Barbacane RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Reale M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Conti P."
Processing 00000000.tx.345: Localization of the e-NOS enzyme in endothelial cells and odontoblasts of healthy human dental pulp. 

Phrase: "Localization of the e-NOS enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "odontoblasts of healthy human dental pulp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0028875:Odontoblasts [Cell]
Processing 00000000.tx.346: Life Sci 68: 297306, 2000.[CrossRef][ISI][Medline] Fleming I and Busse R. 

Phrase: "Life Sci 68"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0376558:Life [Idea or Concept]
   827   C0450387:68 [Intellectual Product]
   827   C3642273:SCI [Professional or Occupational Group]
   743 E C0595998:lives [Finding]

Phrase: ":"

Phrase: "297306,"

Phrase: "2000."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fleming I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Busse R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.347: Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. 

Phrase: "Molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in the regulation of the endothelial nitric oxide synthase."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   782   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   760   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0014257:Endothelial [Tissue]
   739   C0030015:oxide [Inorganic Chemical]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1314939:Involved [Functional Concept]
   739   C1327622:Regulation [Biologic Function]
   739   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.348: Am J Physiol Regul Integr Comp Physiol 284: R1R12, 2003.[Abstract/Free FullText] Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, and Busse R. 

Phrase: "Am"

Phrase: "J Physiol Regul Integr Comp Physiol 284"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0056167:COMP [Therapeutic or Preventive Procedure]
   795   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "R1R12,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fleming I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fisslthaler B,"

Phrase: "Dimmeler S,"

Phrase: "Kemp"

Phrase: "BE"

Phrase: ","

Phrase: "and"

Phrase: "Busse R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.349: Phosphorylation of Thr495 regulates Ca2+/calmodulin-dependent endothelial nitric oxide synthase activity. 

Phrase: "Phosphorylation of Thr495"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "regulates"

Phrase: "Ca2+/calmodulin-dependent endothelial nitric oxide synthase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1151383:nitric-oxide synthase activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.350: Circ Res 88: E68E75, 2001.[ISI][Medline] Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, Tsuruo T, and Sessa WC. 

Phrase: "Circ Res 88"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "E68E75,"

Phrase: "2001."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fontana J,"

Phrase: "Fulton D,"

Phrase: "Chen Y,"

Phrase: "Fairchild TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "McCabe TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Fujita N,"

Phrase: "Tsuruo T,"

Phrase: "and"

Phrase: "Sessa WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.351: Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. 

Phrase: "Domain mapping studies"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   827   C1283195:Mapping [Activity]
   793 E C0024779:Map [Manufactured Object]
   793 E C0557651:Study [Manufactured Object]
   793 E C1706473:Map [Conceptual Entity]
   793 E C2603343:Study [Research Activity]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that"

Phrase: "the M domain of hsp90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "serves as a molecular scaffold to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0337143:Scaffold [Manufactured Object]
   753   C1521991:Molecular [Qualitative Concept]

Phrase: "regulate"

Phrase: "Akt-dependent phosphorylation of endothelial nitric oxide synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "NO release."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.352: Circ Res 90: 866873, 2002.[Abstract/Free FullText] Frisbee JC and Stepp DW. 

Phrase: "Circ Res 90"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0332520:Circ [Quantitative Concept]
   827   C0439083:>90 [Quantitative Concept]
   827   C0439087:<90 [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "866873,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Frisbee JC"

Phrase: "and"

Phrase: "Stepp DW."
Processing 00000000.tx.353: Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. 

Phrase: "Impaired NO-dependent dilation of skeletal muscle arterioles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0012359:Dilation [Pathologic Function]
   742   C0393293:Dilation [Therapeutic or Preventive Procedure]
   742   C0700124:Dilation [Functional Concept]

Phrase: "in hypertensive diabetic obese Zucker rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0034719:Rats, Zucker [Mammal]
   804   C0028754:Obese [Disease or Syndrome]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C2700303:Zucker [Mammal]
Processing 00000000.tx.354: Am J Physiol Heart Circ Physiol 281: H1304H1311, 2001.[Abstract/Free FullText] Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 281"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H1304H1311,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fulton D,"

Phrase: "Gratton JP,"

Phrase: "McCabe TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Fontana J,"

Phrase: "Fujio Y,"

Phrase: "Walsh K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Franke TF,"

Phrase: "Papapetropoulos A,"

Phrase: "and"

Phrase: "Sessa WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.355: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. 

Phrase: "Regulation of endothelium-derived nitric oxide production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by the protein kinase Akt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0812228:AKT [Gene or Genome]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.356: Nature 399: 597601, 1999.[CrossRef][ISI][Medline] Fulton D, Gratton JP, and Sessa WC. 

Phrase: "Nature 399"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "597601,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fulton D,"

Phrase: "Gratton JP,"

Phrase: "and"

Phrase: "Sessa WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.357: Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? 

Phrase: "Post-translational control of endothelial nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0243148:control [Qualitative Concept]
   744   C0687676:Post [Temporal Concept]
   744   C1519614:Translational [Genetic Function]
   744   C1550141:Control [Substance]
   744   C1704687:Post [Manufactured Object]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "why"

Phrase: "isn't"

Phrase: "calcium/calmodulin enough?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006772:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1366910:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.358: J Pharmacol Exp Ther 299: 818824, 2001.[Abstract/Free FullText] Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, and Sessa WC. 

Phrase: "J Pharmacol Exp Ther 299"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "818824,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Garcia-Cardena G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Fan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Shah V,"

Phrase: "Sorrentino R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Cirino G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Papapetropoulos A,"

Phrase: "and"

Phrase: "Sessa WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.359: Dynamic activation of endothelial nitric oxide synthase by Hsp90. 

Phrase: "Dynamic activation of endothelial nitric oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "by Hsp90."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243044:HSP90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1825534:Hsp90 [Gene or Genome]
  1000   C3273507:Hsp90 [Gene or Genome]
Processing 00000000.tx.360: Nature 392: 821824, 1998.[CrossRef][ISI][Medline] Harris MB, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, Chen ZP, Kemp BE, and Venema RC. 

Phrase: "Nature 392"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "821824,"

Phrase: "1998."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Harris MB,"

Phrase: "Ju H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Venema VJ,"

Phrase: "Liang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Zou R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Michell BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Chen ZP,"

Phrase: "Kemp"

Phrase: "BE"

Phrase: ","

Phrase: "and"

Phrase: "Venema RC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]
Processing 00000000.tx.361: Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. 

Phrase: "Reciprocal phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "regulation of endothelial nitric-oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   716   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to bradykinin stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.362: J Biol Chem 276: 1658716591, 2001.[Abstract/Free FullText] He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, and Vogelstein B. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1658716591,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "He TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041405:TC [Geographic Area]
  1000   C1824670:TC [Gene or Genome]
  1000   C3272447:TC [Gene or Genome]

Phrase: "Zhou S,"

Phrase: "da Costa LT,"

Phrase: "Yu J,"

Phrase: "Kinzler KW,"

Phrase: "and"

Phrase: "Vogelstein B."
Processing 00000000.tx.363: A simplified system for generating recombinant adenoviruses. 

Phrase: "A simplified system for generating recombinant adenoviruses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
Processing 00000000.tx.364: Proc Natl Acad Sci USA 95: 25092514, 1998.[Abstract/Free FullText] Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, and Fishman MC. 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "25092514,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Huang PL,"

Phrase: "Huang Z,"

Phrase: "Mashimo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bloch KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Moskowitz MA,"

Phrase: "Bevan JA,"

Phrase: "and"

Phrase: "Fishman MC."
Processing 00000000.tx.365: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. 

Phrase: "Hypertension in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020538:Hypertension [Disease or Syndrome]
   790   C1963138:Hypertension [Finding]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the gene for endothelial nitric oxide synthase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.366: Nature 377: 239242, 1995.[CrossRef][ISI][Medline] Ignarro LJ, Buga GM, Wood, KS, Byrns RE, and Chaudhuri G. 

Phrase: "Nature 377"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "239242,"

Phrase: "1995."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ignarro LJ,"

Phrase: "Buga GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541894:ks [Quantitative Concept]

Phrase: "Byrns RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "and"

Phrase: "Chaudhuri G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.367: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. 

Phrase: "Endothelium-derived relaxing factor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0028128:Endothelium-Derived Relaxing Factor [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C1258027:Endothelium-Derived Relaxing Factor [Biologically Active Substance]
   812   C0014257:Endothelium [Tissue]
   812   C0542193:relaxing [Qualitative Concept]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
   779 E C0035028:Relax [Activity]

Phrase: "produced"

Phrase: "and"

Phrase: "released from artery"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0003842:Artery [Body Part, Organ, or Organ Component]
   790   C0226004:artery [Body System]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]
   718 E C0221464:Arterial [Spatial Concept]

Phrase: "and"

Phrase: "vein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042449:Vein [Body Part, Organ, or Organ Component]
  1000   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "nitric oxide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.368: Proc Natl Acad Sci USA 84: 92659269, 1987.[Abstract] Johnson PR, Greenwood MR, Horwitz BA, and Stern JS. 

Phrase: "Proc Natl Acad Sci USA 84"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "92659269,"

Phrase: "1987."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Johnson PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Greenwood MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Horwitz BA,"

Phrase: "and"

Phrase: "Stern JS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]
Processing 00000000.tx.369: Animal models of obesity: genetic aspects. 

Phrase: "Animal models of obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599779:Models, Animal [Animal]
   770   C0003062:Animal [Animal]
   770   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "genetic aspects."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017399:genetic aspects [Biologic Function]
   827   C1547011:Aspect [Quantitative Concept]
   827   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.370: Annu Rev Nutr 11: 325353, 1991.[CrossRef][ISI][Medline] Jungersten L, Edlund A, Petersson AS, and Wennmalm A. 

Phrase: "Annu Rev Nutr 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "325353,"

Phrase: "1991."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jungersten L,"

Phrase: "Edlund A,"

Phrase: "Petersson AS,"

Phrase: "and"

Phrase: "Wennmalm A."
Processing 00000000.tx.371: Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. 

Phrase: "Plasma nitrate as an index of nitric oxide formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0028125:Nitrate [Chemical Viewed Structurally]
   742   C0699857:Nitrate [Inorganic Chemical]

Phrase: "in man"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024554:MAN [Finding]
  1000   C0025266:Man [Population Group]
  1000   C0086418:Man [Human]

Phrase: ":"

Phrase: "analyses of kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0002778:Analysis [Laboratory Procedure]
   756   C0936012:Analysis [Research Activity]
   756   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "confounding factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.372: Clin Physiol 16: 369379, 1996.[ISI][Medline] Kasiske BL, O'Donnell MP, and Keane WF. 

Phrase: "Clin Physiol 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "369379,"

Phrase: "1996."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kasiske BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "O'Donnell MP,"

Phrase: "and"

Phrase: "Keane WF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]
Processing 00000000.tx.373: The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. 

Phrase: "The Zucker rat model of obesity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "hyperlipidemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020473:Hyperlipidaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "renal injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0160420:Renal injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.374: Hypertension 19: I110I115, 1992.[ISI][Medline] Katakam PV, Ujhelyi MR, Hoenig ME, and Miller AW. 

Phrase: "Hypertension 19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: ":"

Phrase: "I110I115,"

Phrase: "1992."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Katakam PV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032463:PV [Neoplastic Process]

Phrase: "Ujhelyi MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Hoenig"

Phrase: "ME,"

Phrase: "and"

Phrase: "Miller AW."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]
Processing 00000000.tx.375: Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. 

Phrase: "Endothelial dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0856169:endothelial dysfunction [Disease or Syndrome]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "precedes"

Phrase: "hypertension in diet-induced insulin resistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020538:Hypertension [Disease or Syndrome]
   753   C1963138:Hypertension [Finding]
Processing 00000000.tx.376: Am J Physiol Regul Integr Comp Physiol 275: R788R792, 1998.[Abstract/Free FullText] Keller KB and Lemberg L. 

Phrase: "Am"

Phrase: "J Physiol Regul Integr Comp Physiol 275"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0056167:COMP [Therapeutic or Preventive Procedure]
   795   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "R788R792,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Keller KB"

Phrase: "and"

Phrase: "Lemberg L."
Processing 00000000.tx.377: Obesity and the metabolic syndrome. 

Phrase: "Obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "the metabolic syndrome."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0524620:Metabolic syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]
Processing 00000000.tx.378: Am J Crit Care 12: 167170, 2003.[Free FullText] Koshinaka K, Oshida Y, Han YQ, Ohsawa I, and Sato Y. 

Phrase: "Am"

Phrase: "J Crit Care 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1947933:Care [Activity]

Phrase: ":"

Phrase: "167170,"

Phrase: "2003."

Phrase: "[Free FullText"

Phrase: "] Koshinaka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Oshida Y,"

Phrase: "Han YQ,"

Phrase: "Ohsawa I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Sato Y."
Processing 00000000.tx.379: The effect of nitric oxide synthase inhibitor on improved insulin action by pioglitazone in high-fructose-fed rats. 

Phrase: "The effect of nitric oxide synthase inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on improved insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441472:Action [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3266814:Action [Activity]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "by pioglitazone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071097:pioglitazone [Organic Chemical,Pharmacologic Substance]

Phrase: "in high-fructose-fed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
Processing 00000000.tx.380: Metabolism 53: 2227, 2004.[CrossRef][ISI][Medline] Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, and King GL. 

Phrase: "Metabolism 53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "2227,"

Phrase: "2004."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuboki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Jiang ZY,"

Phrase: "Takahara N,"

Phrase: "Ha SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Igarashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamauchi T,"

Phrase: "Feener EP,"

Phrase: "Herbert TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Rhodes CJ,"

Phrase: "and"

Phrase: "King GL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]
Processing 00000000.tx.381: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. 

Phrase: "Regulation of endothelial constitutive nitric oxide synthase gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   807   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "in endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: ":"

Phrase: "a specific vascular action of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]
Processing 00000000.tx.382: Circulation 101: 676681, 2000.[Abstract/Free FullText] Lin MI, Fulton D, Babbitt R, Flemming I, Busse R, Pritchard KA Jr, and Sessa WC. 

Phrase: "Circulation 101"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "676681,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lin MI,"

Phrase: "Fulton D,"

Phrase: "Babbitt R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Flemming I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Busse R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Pritchard KA Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Sessa WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.383: Phosphorylation of threonine 497 in endothelial nitric oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. 

Phrase: "Phosphorylation of threonine 497"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in endothelial nitric oxide synthase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "coordinates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinate [Finding]
  1000   C0700114:coordinate [Functional Concept]
  1000   C1707511:Coordinate [Spatial Concept]

Phrase: "the coupling of L-arginine metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1948027:Coupling [Functional Concept]

Phrase: "to efficient nitric oxide production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]
Processing 00000000.tx.384: J Biol Chem 278: 4471944726, 2003.[Abstract/Free FullText] Meigs JB. 

Phrase: "J Biol Chem 278"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "4471944726,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Meigs JB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]
Processing 00000000.tx.385: Epidemiology of the insulin resistance syndrome. 

Phrase: "Epidemiology of the insulin resistance syndrome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   753   C0014508:epidemiology [Functional Concept]
   753   C0699910:epidemiology [Health Care Activity]
Processing 00000000.tx.386: Curr Diab Rep 3: 7379, 2003.[Medline] Miatello R, Risler N, Castro C, Gonzalez S, Ruttler M, and Cruzado M. 

Phrase: "Curr Diab Rep 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1744664:REP [Molecular Function]

Phrase: ":"

Phrase: "7379,"

Phrase: "2003."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miatello R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Risler N,"

Phrase: "Castro C,"

Phrase: "Gonzalez S,"

Phrase: "Ruttler M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Cruzado M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.387: Aortic smooth muscle cell proliferation and endothelial nitric oxide synthase activity in fructose-fed rats. 

Phrase: "Aortic smooth muscle cell proliferation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C1658578:smooth muscle cell proliferation [Cell Function]
   884   C2246389:muscle cell proliferation [Cell Function]
   840   C0596290:Cell Proliferation [Cell Function]
   804   C0334094:Proliferation [Pathologic Function]
   804   C1514485:Proliferation [Functional Concept]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "and"

Phrase: "endothelial nitric oxide synthase activity in fructose-fed rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C1151383:nitric-oxide synthase activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.388: Am J Hypertens 14: 11351141, 2001.[CrossRef][ISI][Medline] Michell BJ, Harris MB, Chen ZP, Ju H, Venema VJ, Blackstone MA, Huang W, Venema RC, and Kemp BE. 

Phrase: "Am"

Phrase: "J Hypertens 14"

Phrase: ":"

Phrase: "11351141,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Michell BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Harris MB,"

Phrase: "Chen ZP,"

Phrase: "Ju H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Venema VJ,"

Phrase: "Blackstone MA,"

Phrase: "Huang W,"

Phrase: "Venema RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "and"

Phrase: "Kemp"

Phrase: "BE."
Processing 00000000.tx.389: Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. 

Phrase: "Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0020792:Identification [Mental Process]
   735   C0205396:Identification [Qualitative Concept]

Phrase: "at serine 617"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "serine 635."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.390: J Biol Chem 277: 4234442351, 2002.[Abstract/Free FullText] Miller AW, Sims JJ, Canavan A, Hsu T, and Ujhelyi MR. 

Phrase: "J Biol Chem 277"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "4234442351,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Miller AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Sims JJ,"

Phrase: "Canavan A,"

Phrase: "Hsu T,"

Phrase: "and"

Phrase: "Ujhelyi MR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]
Processing 00000000.tx.391: Impaired vagal reflex activity in insulin-resistant rats. 

Phrase: "Impaired vagal reflex activity in insulin-resistant rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1145751:insulin activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.392: J Cardiovasc Pharmacol 33: 698702, 1999.[CrossRef][ISI][Medline] Okon EB, Szado T, Laher I, McManus B, and van Breemen C. 

Phrase: "J Cardiovasc Pharmacol 33"

Phrase: ":"

Phrase: "698702,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Okon EB,"

Phrase: "Szado T,"

Phrase: "Laher I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "McManus B,"

Phrase: "and"

Phrase: "van Breemen C."
Processing 00000000.tx.393: Augmented contractile response of vascular smooth muscle in a diabetic mouse model. 

Phrase: "Augmented contractile response of vascular smooth muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "in a diabetic mouse model."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Model [Intellectual Product]
Processing 00000000.tx.394: J Vasc Res 40: 520530, 2003.[CrossRef][ISI][Medline] Palmer RM, Ferrige AG, and Moncada S. 

Phrase: "J Vasc Res 40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439509:/40 [Temporal Concept]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "520530,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Palmer RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Ferrige AG,"

Phrase: "and"

Phrase: "Moncada S."
Processing 00000000.tx.395: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. 

Phrase: "Nitric oxide release accounts for the biological activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1551359:account [Idea or Concept]
   711   C2741673:Account # [Clinical Attribute]
   711   C2981730:Account [Classification]

Phrase: "of endothelium-derived relaxing factor."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0028128:Endothelium-Derived Relaxing Factor [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C1258027:Endothelium-Derived Relaxing Factor [Biologically Active Substance]
   812   C0014257:Endothelium [Tissue]
   812   C0542193:relaxing [Qualitative Concept]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
   779 E C0035028:Relax [Activity]
Processing 00000000.tx.396: Nature 327: 524526, 1987.[CrossRef][ISI][Medline] Pritchard KA, Ackerman AW, Ou J, Curtis M, Smalley DM, Fontana JT, Stemerman MB, and Sessa WC. 

Phrase: "Nature 327"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "524526,"

Phrase: "1987."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pritchard KA,"

Phrase: "Ackerman AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Ou J,"

Phrase: "Curtis M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Smalley DM,"

Phrase: "Fontana JT,"

Phrase: "Stemerman MB,"

Phrase: "and"

Phrase: "Sessa WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.397: Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. 

Phrase: "Native low-density lipoprotein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   812   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0178587:density [Quantitative Concept]
   812   C0205251:low [Qualitative Concept]
   812   C0302891:Native [Functional Concept]
   812   C1299352:Low [Qualitative Concept]
   812   C1550472:low [Idea or Concept]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "endothelial nitric oxide synthase dysfunction"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   897   C0856169:endothelial dysfunction [Disease or Syndrome]
   804   C0031847:dysfunction [Functional Concept]
   804   C0277785:Dysfunction, NOS [Qualitative Concept]
   771   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   771   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   771   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   748 E C0231174:Malfunction [Functional Concept]
   748 E C1881681:MALFUNCTION [Phenomenon or Process]
   717   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "role of heat shock protein 90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   716   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "caveolin-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0379710:caveolin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           caveolin
  1000   C1332669:CAVEOLIN 1 [Gene or Genome]
   861   C0887901:caveolin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.398: Free Radic Biol Med 33: 5262, 2002.[CrossRef][ISI][Medline] Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, and Sessa WC. 

Phrase: "Free Radic Biol Med 33"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "5262,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pritchard KA Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Ackerman AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Gross ER,"

Phrase: "Stepp DW,"

Phrase: "Shi Y,"

Phrase: "Fontana JT,"

Phrase: "Baker JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "and"

Phrase: "Sessa WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.399: Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. 

Phrase: "Heat shock protein 90"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243044:Heat Shock Protein 90 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the balance of nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014653:Balance [Organism Function]
   760   C0205415:Balance [Functional Concept]
   760   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "superoxide anion from endothelial nitric-oxide synthase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   748   C0003075:Anion [Element, Ion, or Isotope]
Processing 00000000.tx.400: J Biol Chem 276: 1762117624, 2001.[Abstract/Free FullText] Salt IP, Morrow VA, Brandie FM, Connell JM, and Petrie JR. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1762117624,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Salt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0036140:Salt [Chemical Viewed Structurally]
  1000   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C0206136:Salt [Food,Inorganic Chemical]
   928 E C1537053:salty [Qualitative Concept]
   900 E C0678584:saltiness [Qualitative Concept]

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: ","

Phrase: "Morrow VA,"

Phrase: "Brandie FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Connell JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "and"

Phrase: "Petrie JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.401: High glucose inhibits insulin-stimulated nitric oxide production without reducing endothelial nitric-oxide synthase Ser1177 phosphorylation in human aortic endothelial cells. 

Phrase: "High glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin-stimulated nitric oxide production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033268:production [Occupational Activity]

Phrase: "without reducing endothelial nitric-oxide synthase Ser1177 phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0031715:Phosphorylation [Molecular Function]
   795   C1158886:Phosphorylation [Molecular Function]
   710   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   710   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]

Phrase: "in human aortic endothelial cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0003483:Aortic [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C0086418:Human [Human]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.402: J Biol Chem 278: 1879118797, 2003.[Abstract/Free FullText] Scherrer U, Randin D, Vollenweider P, Vollenweider L, and Nicod P. 

Phrase: "J Biol Chem 278"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1879118797,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scherrer U,"

Phrase: "Randin D,"

Phrase: "Vollenweider P,"

Phrase: "Vollenweider L,"

Phrase: "and"

Phrase: "Nicod P."
Processing 00000000.tx.403: Nitric oxide release accounts for insulin's vascular effects in humans. 

Phrase: "Nitric oxide release accounts for insulin's vascular effects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1551359:account [Idea or Concept]
   711   C2741673:Account # [Clinical Attribute]
   711   C2981730:Account [Classification]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.404: J Clin Invest 94: 25112515, 1994.[ISI][Medline] Schwaninger RM, Sun H, and Mayhan WG. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "94"

Phrase: ":"

Phrase: "25112515,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schwaninger RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Sun H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mayhan WG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]
Processing 00000000.tx.405: Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats. 

Phrase: "Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0012356:Dilatation [Therapeutic or Preventive Procedure]
   742   C0012359:Dilatation [Pathologic Function]

Phrase: "in type II diabetic rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
Processing 00000000.tx.406: Life Sci 73: 34153425, 2003.[CrossRef][ISI][Medline] Shankar RR, Wu Y, Shen HQ, Zhu JS, and Baron AD. 

Phrase: "Life Sci 73"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0376558:Life [Idea or Concept]
   827   C3642273:SCI [Professional or Occupational Group]
   743 E C0595998:lives [Finding]

Phrase: ":"

Phrase: "34153425,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shankar RR,"

Phrase: "Wu Y,"

Phrase: "Shen HQ,"

Phrase: "Zhu JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Baron AD."
Processing 00000000.tx.407: Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. 

Phrase: "Mice with gene disruption of both endothelial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1417166:MICE gene [Gene or Genome]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "neuronal nitric oxide synthase exhibit insulin resistance."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   818   C0021655:Insulin Resistance [Pathologic Function]
   818   C2700570:INSULIN RESISTANCE [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0237834:Resistance [Mental Process]
   795   C1514892:Resistance [Physiologic Function]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   724 E C0332325:Resistant [Functional Concept]
   724 E C1550464:resistent [Idea or Concept]
   724 E C2827757:RESISTANT [Laboratory or Test Result]
   712 E C3537244:Insulins [Pharmacologic Substance]
   710   C0669368:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0907533:Neuronal Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.408: Diabetes 49: 684687, 2000.[Abstract] Shinozaki K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Masada M, Toda N, and Kikkawa R. 

Phrase: "Diabetes 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "684687,"

Phrase: "2000."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shinozaki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kashiwagi A,"

Phrase: "Nishio Y,"

Phrase: "Okamura T,"

Phrase: "Yoshida Y,"

Phrase: "Masada M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Toda N,"

Phrase: "and"

Phrase: "Kikkawa R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.409: Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2 imbalance in insulin-resistant rat aorta. 

Phrase: "Abnormal biopterin metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "a major cause of impaired endothelium-dependent relaxation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0015127:cause [Functional Concept]
   744   C0205164:Major [Qualitative Concept]
   744   C1524003:Cause [Conceptual Entity]

Phrase: "through nitric oxide/O2 imbalance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1397014:Imbalance [Sign or Symptom]

Phrase: "in insulin-resistant rat aorta."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1882561:Rat Aorta [Body Part, Organ, or Organ Component]
   812   C0003483:Aorta [Body Part, Organ, or Organ Component]
   812   C1278934:Aorta [Body Part, Organ, or Organ Component]
Processing 00000000.tx.410: Diabetes 48: 24372445, 1999.[Abstract] Singleton JR, Smith AG, Russell JW, and Feldman EL. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "24372445,"

Phrase: "1999."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Singleton JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Smith AG,"

Phrase: "Russell JW,"

Phrase: "and"

Phrase: "Feldman EL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]
Processing 00000000.tx.411: Microvascular complications of impaired glucose tolerance. 

Phrase: "Microvascular complications of impaired glucose tolerance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0009566:Complications [Pathologic Function]
   753   C1171258:complications [Pathologic Function]
   719 E C2362589:Complication [Idea or Concept]
Processing 00000000.tx.412: Diabetes 52: 28672873, 2003.[Abstract/Free FullText] Sowers JR, Epstein M, and Frohlich ED. 

Phrase: "Diabetes 52"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "28672873,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sowers JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Epstein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Frohlich ED."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]
Processing 00000000.tx.413: Diabetes, hypertension, and cardiovascular disease: an update. 

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "cardiovascular disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "an update."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519814:Update [Temporal Concept]
Processing 00000000.tx.414: Hypertension 37: 10531059, 2001.[Abstract/Free FullText] Stalker TJ, Skvarka CB, and Scalia R. 

Phrase: "Hypertension 37"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: ":"

Phrase: "10531059,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Stalker TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Skvarka CB,"

Phrase: "and"

Phrase: "Scalia R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.415: A novel role for calpains in the endothelial dysfunction of hyperglycemia. 

Phrase: "A novel role for calpains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the endothelial dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0856169:endothelial dysfunction [Disease or Syndrome]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "of hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.416: FASEB J 17: 15111513, 2003.[Abstract/Free FullText] Steinberg HO, Brechtel G, Johnson A, Fineberg N, and Baron AD. 

Phrase: "FASEB J 17"

Phrase: ":"

Phrase: "15111513,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Steinberg HO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832110:HO [Gene or Genome]

Phrase: "Brechtel G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Johnson A,"

Phrase: "Fineberg N,"

Phrase: "and"

Phrase: "Baron AD."
Processing 00000000.tx.417: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. 

Phrase: "Insulin-mediated skeletal muscle vasodilation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0042401:Vasodilation [Physiologic Function]
   804   C0595862:VASODILATION [Pathologic Function]
   804   C3537065:Vasodilation [Physiologic Function]

Phrase: "is"

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.418: A novel action of insulin to increase nitric oxide release. 

Phrase: "A novel action of insulin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "nitric oxide release."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.419: J Clin Invest 94: 11721179, 1994.[ISI][Medline] Strojek K. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "94"

Phrase: ":"

Phrase: "11721179,"

Phrase: "1994."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strojek K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.420: Features of macrovascular complications in type 2 diabetic patients. 

Phrase: "Features of macrovascular complications"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]

Phrase: "in type 2 diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.421: Acta Diabetol 40 Suppl 2: S334S337, 2003.[CrossRef][Medline] Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, and Nakao K. 

Phrase: "Acta Diabetol 40 Suppl 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439509:/40 [Temporal Concept]
   804   C0701230:Diabetol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "S334S337,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takaya K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ogawa Y,"

Phrase: "Isse N,"

Phrase: "Okazaki T,"

Phrase: "Satoh N,"

Phrase: "Masuzaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tamura N,"

Phrase: "Hosoda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Nakao K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: Molecular cloning of rat leptin receptor isoform complementary DNAsidentification of a missense mutation in Zucker fatty (fa/fa) rats. 

Phrase: "Molecular cloning of rat leptin receptor isoform complementary DNAsidentification of a missense mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   735   C0009015:Cloning [Research Activity]

Phrase: "in Zucker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700303:Zucker [Mammal]

Phrase: "fatty"

Phrase: "(fa/fa) rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.423: Biochem Biophys Res Commun 225: 7583, 1996.[CrossRef][ISI][Medline] Verma S, Bhanot S, Yao L, and McNeill JH. 

Phrase: "Biochem Biophys Res Commun 225"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "7583,"

Phrase: "1996."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Verma S,"

Phrase: "Bhanot S,"

Phrase: "Yao L,"

Phrase: "and"

Phrase: "McNeill JH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]
Processing 00000000.tx.424: Defective endothelium-dependent relaxation in fructose-hypertensive rats. 

Phrase: "Defective endothelium-dependent relaxation in fructose-hypertensive rats."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0014257:Endothelium [Tissue]
   744   C0035028:Relaxation [Activity]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
Processing 00000000.tx.425: Am J Hypertens 9: 370376, 1996.[CrossRef][ISI][Medline] Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL, and Kahn CR. 

Phrase: "Am"

Phrase: "J Hypertens 9"

Phrase: ":"

Phrase: "370376,"

Phrase: "1996."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vicent D,"

Phrase: "Ilany J,"

Phrase: "Kondo T,"

Phrase: "Naruse K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fisher SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Kisanuki YY,"

Phrase: "Bursell S,"

Phrase: "Yanagisawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "King"

Phrase: "GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: "and"

Phrase: "Kahn CR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]
Processing 00000000.tx.426: The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. 

Phrase: "The role of endothelial insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of vascular tone"

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.427: J Clin Invest 111: 13731380, 2003.[Abstract/Free FullText] Walchli S, Curchod ML, Gobert RP, Arkinstall S, and Hooft van Huijsduijnen R. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "111"

Phrase: ":"

Phrase: "13731380,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Walchli S,"

Phrase: "Curchod ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Gobert RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Arkinstall S,"

Phrase: "and"

Phrase: "Hooft van Huijsduijnen R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.428: Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. 

Phrase: "Identification of tyrosine phosphatases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "that"

Phrase: "dephosphorylate"

Phrase: "the insulin receptor."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.429: A brute force approach based on "substrate-trapping" mutants. 

Phrase: "A brute force approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "based"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1527178:Based [Functional Concept]
  1000   C1705938:Based [Idea or Concept]
   966 E C0002055:base [Inorganic Chemical]
   966 E C0178499:Base [Chemical Viewed Functionally]
   966 E C1880279:Base [Biomedical or Dental Material]

Phrase: "on ""substrate-trapping"" mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.430: J Biol Chem 275: 97929796, 2000.[Abstract/Free FullText] Watson KE, Peters Harmel AL, and Matson G. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "97929796,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Watson KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Peters Harmel AL,"

Phrase: "and"

Phrase: "Matson G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.431: Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance. 

Phrase: "Atherosclerosis in type 2 diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0004153:Atherosclerosis [Disease or Syndrome]
   716   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
   716   C2984301:Type II diabetes mellitus [Functional Concept]

Phrase: ":"

Phrase: "the role of insulin resistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.432: J Cardiovasc Pharmacol Ther 8: 253260, 2003.[Medline] Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, Kaminiski PM, Wolin MS, and Hintze TH. 

Phrase: "J Cardiovasc Pharmacol Ther 8"

Phrase: ":"

Phrase: "253260,"

Phrase: "2003."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zeballos GA,"

Phrase: "Bernstein RD,"

Phrase: "Thompson CI,"

Phrase: "Forfia PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Seyedi N,"

Phrase: "Shen W,"

Phrase: "Kaminiski PM, Wolin MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C2349943:Ms. [Conceptual Entity]
   812   C3539704:MS [Gene or Genome]

Phrase: "and"

Phrase: "Hintze TH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]
Processing 00000000.tx.433: Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. 

Phrase: "Pharmacodynamics of plasma nitrate/nitrite"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243145:pharmacodynamics [Functional Concept]
   760   C0851347:Pharmacodynamics [Biologic Function]

Phrase: "as an indication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392360:indication [Idea or Concept]
  1000   C3146298:Indication [Functional Concept]

Phrase: "of nitric oxide formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1157570:nitric oxide formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "in conscious dogs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012984:Dogs [Mammal]
   861   C1280551:Dogs [Mammal]
Processing 00000000.tx.434: Circulation 91: 29822988, 1995.[Abstract/Free FullText]

Phrase: "Circulation 91"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "29822988,"

Phrase: "1995."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

